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Abstract
This thesis is divided in 2 sections, each describing the development of an oxidore-
ductase based biosensor. In the first part human Cytochrome P450 1A2 (CYP1A2) electro-
chemistry was studied, while the second is focused on the optimization of immobiliza-
tion platforms and operation methods for amperometric biosensors, using cytochrome c
nitrite reductase (ccNiR), (Desulfovibrio desulfuricans ATCC 27774) as a model enzyme.
The direct electrochemistry of P450s immobilized in water-based sol-gel thin films
was described for the first time. The optimization of the film showed that only the com-
bination of the inorganic matrix and the PEG400 enabled the direct electron transfer re-
action and electrocatalytic activity towards oxygen. The amount of dissolved oxygen
in solution revealed itself a significant feature in CYP’s electrochemistry – in anaerobic
conditions, when small amounts of oxygen are added the PFeIII/II signal’s intensity in-
creased, while in aerobic conditions it disappeared; probably PFeIII is not being regen-
erated. However, this was not observed with the CYPOR complex, indicating that the
reductase has an essential role in the CYP’s catalytic cycle completion; this was also sus-
tained by the fact that only in its presence organic substrates catalysis (caffeine) occurs.
The hybrid sol-gel developed for CYP, was optimized for a nitrite biosensor. ccNiR
was successfully incorporated while promptly displaying catalytic currents. Although
the bioelectrode’s response decreases after day one, it was able to maintain a reasonable
catalytic activity over a time span of 2 weeks. Another electrode modification strategy,
studied with ccNiR, was based on the electrophoretic deposition of macroporous assem-
blies of single-walled carbon nanotubes. The macroporous structure was created as a
result of the presence of polystyrene beads co-deposited with the carbon nanotubes. An
increase in the amount of material was correlated with a higher enzyme activity.
Finally, an oxygen scavenger system consisting of glucose oxidase, glucose, and cata-
lase was employed for oxygen removal in an open electrochemical cell. The system com-
pletely removed oxygen for over 1 h and was successfully applied to a ccNiR based nitrite
sensor.
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Resumo
O presente trabalho encontra-se dividido em duas secções, cada um descrevendo o
desenvolvimento de um biossensor baseado em oxidorredutases. Na primeira secção,
foi estudada a eletroquímica do citocromo P450 1A2 (CYP1A2), enquanto que a segunda
se foca na otimização de plataformas de imobilização e métodos de operação para bios-
sensores amperométricos, usando a redutase do nitrito multihémica (ccNiR) extraída de
Desulfovibrio desulfuricans ATCC27774 como um enzima modelo.
A electroquímica direta de P450 imobilizado em filmes à base de filmes de sol-gel
aquoso foi descrita pela primeira vez. A otimização da composição do material mostrou
que a combinação da matriz inorgânica e o PEG400 facilitava grandemente a transferên-
cia de electrões directa. A quantidade de oxigénio dissolvido na solução revelou-se uma
característica importante em electroquímica do CYP - em condições anaeróbicas, em que
as pequenas quantidades de oxigénio foram adicionados, a intensidade do sinal PFeIII/II
aumentou, enquanto que em condições aeróbicas desapareceu; provavelmente o PFeIII
não estava a ser regenerado. No entanto, o mesmo não foi observado com o complexo
CYPOR, indicando que a redutase tem um papel essencial na conclusão do ciclo catalí-
tico do CYP, o que também foi sustentado pelo facto de apenas na sua presença ocorrer a
catálise de substratos orgânicos (cafeína).
O sol-gel híbrido desenvolvido para o CYP, foi adaptado para um biossensor de ni-
trito no qual a ccNiR foi incorporada com sucesso. Embora a resposta do bioeléctrodo
tenha diminuido após o primeiro dia, a atividade catalítica foi mantida a um nivel razoá-
vel ao longo de um intervalo de tempo de 2 semanas. Outra estratégia de modificação do
eletrodo estudada com ccNiR, foi baseada na deposição eletroforética de nanotubos de
carbono macroporosos. A estrutura macroporosa foi criado como resultado da presença
de esferas de poliestireno co-depositadas com os nanotubos de carbono. Um aumento na
quantidade de material foi correlacionado com o aumento da actividade enzimática.
Finalmente, um sistema eliminador de oxigénio consistindo em glucose oxidase, glu-
cose e catalase, foi empregue para a remoção de oxigénio de uma célula electroquímica
xi
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aberta. O sistema removeu completamente o oxigénio durante mais 1 h e foi aplicado
com êxito a um sensor de nitrito baseado na ccNiR.
Palavras-chave: biosensors, reductase do nitrito multihémica, citocromo P4501A2, trans-
ferência electrónica, sol-gel, deposição electroforética.
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Introduction
1.1 Electrochemical Biosensors
1.1.1 Importance
The sensitive and selective determination of a large number of compounds is of great
relevance, and has always been a problem of the utmost importance scientific research.
In the field of health-care, it is indispensable for the diagnosis of diseases. Biotechnology,
too, requires the analysis of complex media. High selectivity, even in trace analysis, has
been achieved by the considerable progress in analytical instrumentation, as is reflected
by modern gas chromatography, high-pressure liquid chromatography, mass spectrome-
try and atomic absorption spectroscopy. However, due to the high costs associated with
these powerful instrumental techniques they are only used in specialized laboratories.
The development of methods highly selective and easy to handle is thus a key issue in
analysis. Whereas reliable sensors are available for the determination of physical pa-
rameters, e.g. temperature, pressure, or sound energy, the qualitative and quantitative
analysis of chemical composition remains difficult. Electrochemical sensors, such as pH
electrodes and Clark-type electrodes for oxygen measurement are widely used for this
purpose1-3. Biosensors may be the answer to these problems.
1.1.2 History
The term biosensor was devised by Karl Camman in 1977. He defined it as a chemical
sensor where the recognition system uses a biochemical mechanism. However, the IU-
PAC did not agree on the implementation of the term until 1997. Whereupon, the IUPAC
1
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committee came up with their own definition, comprising Camman’s definition plus sev-
eral parameters that must be fulfilled (see below)2.
Even though Karl Camman was the one who laid claim to the term, Leland C. Clark is
considered by many the father of biosensors. He had developed the first bubble oxygena-
tor for use in cardiac surgery. Conversely, when he came to publish his results, his article
was refused by the editor since the oxygen tension in the blood coming out from the de-
vice could not be measured. This instigated Clark to develop the oxygen electrode4, with
which he meant to measure the reduction of oxygen with a platinum electrode in order
to determine the oxygenation of blood5. His first sensor failed because the blood compo-
nents would adsorb on the electrode’s surface, which in turn distorted the signal. Later
on, Clark had the idea, which would change the history of biosensors, of using the cello-
phane wrapper of a cigarette packet on his sensor, making it so that only low molecular
weight substances, mainly oxygen, could reach the electrode surface and be measured.
The reduction current indicated the oxygen concentration, and so the Clark electrode
was created2. Nowadays, Teflon is used as the membrane and this sensor remains a key
tool in medicine and environmental monitoring. Afterwards, Clark developed the sensor
further by entrapping concentrated glucose oxidase (GOx) with another semi-permeable
membrane in front of the electrode, which could then be used for multiple glucose mea-
surements based on the monitoring of the reaction described on equation 1.16.
glucose+O2
glucose oxidase−−−−−−−−→ gluconic acid+H2O2 (1.1)
The enzyme layer became an integrated part of the sensor. Lee Clark went on to coin the
term “enzyme electrode” at a meeting of the New York Academy of Sciences in 19622. It
was this electrode arrangement that introduced the new sensor concept - the biosensor.
A few years later, hydrogen peroxide reduction was detected on the electrode instead
of oxygen, due to limitations concerning this particular system, namely, oxygen fluctua-
tions, substrate limitations/sensitivity, electrochemical interferences, among others7.
Clark’s system has been thoroughly studied and modified throughout the years, for
several different purposes, one of which – an oxygen scavenging system – will be ex-
plored in this thesis.
Figure 1.1: Clark electrode functioning.
2
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Because of the volume of the literature regarding amperometric biosensors as well as
space limitations it is not possible to cite all contributions to the field. It was selected
representative work in the field of electrochemical biosensing. General milestones and
achievements relevant to biosensor research and development are listed in Table 1.1.
3
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Table 1.1: Historical landmarks in the development of enzyme based electrochemical
biosensors.
Date Event References 
1962 First glucose enzyme electrode Clark, L. C. & Lyons, C.5 
1973 Glucose enzyme electrode based on peroxide detection Guilbault, G. G. & Lubrano, G. J.8 
1975 Launch of the first commercial glucose sensor system YSI Inc. 
1977 Karl Cammann introduced the term “ biosensor ”  Cammann, K.9 
1977 Reversible ET of cytochrome c was obtained employing tin-doped indium 
oxide electrodes and 4,4′ - bipyridiyl as a promoting monolayer on gold 
electrodes. 
Eddowes, M. J. & Hill, H. A. O.10 
Eddowes, M. J., Hill, H. A. O. & Uosaki, K.11 
1981 Oxidation of NADH at graphite electrodes is described for the first time. Huck, H. & Schmidt, H.-L12 
Jaegfeldt, H. et al13 
1982 Demonstration of in vivo glucose monitoring Shichiri, M. et al.14 
1984 First ferrocene - mediated amperometric glucose biosensor by Cass et al. 
The work led to the development of the first electronic blood glucose 
measuring system which was commercialized by MediSense Inc. (later 
bought by Abbott Diagnostics) in 1987. 
Cass, A. E. G. et al.15 
1987 Launch of the first glucose meter Medisense Inc. 
1987 Electrical wiring of enzymes Degani, Y. & Heller, A.16 
1988 Adam Heller and Yinon Degani introduced the electrical connection 
(“wiring”) of redox centers of enzymes to electrodes through electron - 
conducting redox hydrogels. This work was the basis for continuous 
glucose monitoring employing subcutaneously implanted miniaturized 
glucose biosensors. 
Degani, Y. & Heller, A.17 
Forster, R. J. & Vos, J. G.18; Csöregi, E., 
Schmidtke, D. W. & Heller19 
Schmidtke, D. W.20 
Wagner, J. G. et al.21 
1988 Direct ET by means of immobilized enzymes was introduced Frew, J. E. et al.22–28 
1997 IUPAC introduced for the first time a definition for biosensors in analogy 
to the definition of chemosensors 
Zayats, M. et al.29 
1999 Launch of a commercial in vivo glucose sensor Minimed Inc. 
2000 Introduction of a wearable noninvasive glucose monitor Cygnus Inc. 
2002 Schuhmann et al. introduced the use of electrodeposition paints (EDPs) as 
immobilization matrices for biosensors. Following work enabled the 
incorporation of redox mediators into the polymer structure of EDPs 
Kurzawa, C. et al.30–32 
2007 An implanted glucose biosensor (Freestyle Navigator System) operated 
for five days 
Weinstein, R. L. et al.33 
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1.1.3 Biosensor components
Nowadays, biosensors are characterized by the direct spatial combination of a matrix-
bound biologically active substance - the so-called receptor - with a transducer compo-
nent. For molecular recognition, biosensors may also be equipped with other biologic
elements instead of enzymes. Besides nearly all kinds of electrodes, various other signal
transducers have been combined with the immobilized bio-material34. Examples of these
components are given in Figure 1.2; this compilation helps one to understand which pa-
rameters change during a biological recognition event in a biosensor. The choice of the
transduction process and transduction material is dependent on this knowledge as well
as the chemical approach to construct the sensing layer on the transducer surface.
Figure 1.2: Examples for biosensor components and measured analytes1.
The choice of the biological recognition element is the crucial decision when devel-
oping a novel biosensor device. Most importantly, the bioreceptor needs to selectively
react with the analyte of interest. The bioreceptor needs to be stable under the opera-
tion and should provide a reasonable long-term stability. In Table 1.2 it is possible to see
different types of receptors used in biosensors, that recognize specific species, and the
5
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electrochemical measurement techniques linked to them29.
Table 1.2: Types of receptors used in biosensorsa.35
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Enzymes are by far the most commonly used biological components in biosensors.
Furthermore, electrochemical transduction is the most popular signaling method, with
amperometry (measurement of electric current) the favored configuration. It is advan-
tageous if the chemical structure of the enzyme allows the introduction of additional
functionalities for chemical modification with redox mediators, binding, or crosslinking
with the immobilization matrix. In addition, the potential for tuning the properties of the
redox enzyme by means of genetic or chemical techniques can be helpful for biosensor
optimization. An important factor, especially with respect to potential commercializa-
tion, is that the redox enzyme is available at reasonable costs and effort. This work will
focus on membrane-bound enzymes as the bioreceptor, therefore they will be given spe-
cial attention in this section.
The main advantages of employing enzymes in biosensor architectures are the fol-
lowing:
i) They can exhibit a very high catalytic activity with a turnover on a per mole basis
which makes them not only exceptional bioelectrocatalysts for effective signal am-
plification in biosensors but also for biofuel cells. Good turnover frequencies kcat are
in the range of up to, at least, 100 s-1.
ii) Typically, enzymes have a high selectivity for their substrates.
iii) The driving force - redox potential needed to achieve enzymatic biocatalysis - is often
very close to that of the enzyme’s cofactors. Therefore, biosensors can operate at
moderate potentials.
iv) In several cases, an improvement of the enzyme stability is found when enzymes are
immobilized on transducer surfaces36,37.
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Figure 1.3: Key features of amperometric biosensors1.
Knowing the most influential parameters on a specific biosensor is the basis to un-
derstand and fine tune the performance of these devices in a rational manner. Figure 1.3
summarizes several analytical features of typical biosensors; selectivity, sensitivity, ac-
curacy, response and recovery times, as well as operating lifetime are some of the most
significant key factors.
An essential aspect of biosensor optimization is the elimination/reduction of the im-
pact of interferences. In most samples there are components that either directly react
at the electrode surface or at the involved redox centers, or interfere with the biological
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recognition reaction (e.g., inhibitors or other enzyme substrates). Additional problems
such as leakage from the sensing layer, loss of enzyme activity or electrode fouling may
occur. Therefore, changes in sensitivity and baseline drifts are bound to arise during
biosensor operation. Suitable strategies are needed to ensure reproducible and quantita-
tive results38. For applications aimed for the general public, it is imperative to character-
ize and optimize the biosensor architecture under actual measuring conditions.
Besides dictating the efficiency of electrochemical transduction, the biosensor design
also plays a fundamental role in defining the response features. For example, sensitivity
and response time, which strongly depends on mass transfer limitations, are particularly
influenced by the characteristics of the immobilization matrix39.
1.1.4 Immobilization techniques
The main limitation for successful applications comes from the difficulty to elaborate
reagentless devices in which all components enabling the bioelectrochemical detection
(i.e. enzyme(s), cofactor and electro-catalytic system for cofactor detection and regenera-
tion) are immobilized in a durable and active form40. The immobilization of biomolecules
permits the re-use of costly biological molecule and allows a significant simplification of
the analytical apparatus.
Controlled immobilization techniques are useful to more than allowing the re-use or
continuous use of industrial enzymes. The immobilization and subsequent post-immobilization
techniques can be very advantageous to greatly increase activity–stability properties of
enzymes41. For example, inactivation of multimeric enzymes may be strongly influenced
by the dissociation of subunits. On the other hand conformational changes promoted
by any denaturing agent (heat, pH, organic solvents) on the small fraction of dissociated
monomers could be much more rapid and intense42,43.
The use of biological species such as proteins, peptides, nucleic acids and even whole
cells in biosensors relies largely on the successful immobilization of the bioreceptor in
a physiologically active form. Typical methods to immobilize bioreceptor onto inor-
ganic, organic or polymeric surfaces have been based on physical adsorption44, cova-
lent binding45, entrapment in semi-permeable membranes46 and microencapsulation into
polymer microspheres and hydrogels47,48. Notwithstanding problems such as leaching
and desorption44, denaturation and difficulty controlling the orientation of the biomolecule49,
these methods have proven to be amenable to the immobilization of a large number of
biomolecules.
Various methods have been described for protein immobilization (Table 1.3). In gen-
eral, biosensors using adsorbed enzymes or proteins are insensitive and unstable, except
for a few cases, this procedure alone is rarely used in biosensor construction.
The relative lack of long-term stability in biological molecules is the most serious
limitation in commercializing biosensors. Under some circumstances, the immobilized
9
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Table 1.3: immobilization procedures for enzymes50.
preparation displays a decrease in stability. Chibata51 reports that, of 50 enzyme immo-
bilizations studied, 60% showed an increase in stability, 24% were unaffected and 16%
showed a decrease in stability.
As it is, in this thesis, special attention will be given to sol-gel immobilization and
surfactant films. The interest of sol–gel chemistry for bioencapsulation has been largely
discussed in the literature52 for several types of biosensors, but most importantly it has
been successful in protein immobilization on electrode surfaces53,54. Sol-gel matrices are
produced from a starting colloidal suspension of sol-gel precursors –the sol – which un-
dergoes hydrolysis and condensation reactions to form the gel (Figure 1.4).
The sol-gel entrapment can be a relatively gentle chemical procedure that is carried
out at room temperature so that many of the molecules can endure the entrapment. The
sol-gel methodology has been extensively used to immobilize soluble proteins showing
that the majority of them can be encapsulated with retention of their native structure and
functionality and an enhanced stability52,55–58.
Bioencapsulation within these materials is usually obtained from the hydrolysis of
alkoxide precursors (usually tetraethyl orthosilicate, TEOS, or tetrametyl orthosilicate,
TMOS) resulting in a colloidal sol solution. Subsequently, a buffered aqueous solution
containing the biomolecule of interest is added to the sol producing a polycondensation
reaction that leads to the formation of a transparent highly porous gel that encloses the
species within its pores. The popularity of sol-gel materials can be attributed to this and
other significant factors, namely54:
(a) The ability to generate an almost infinite number of organic- inorganic hybrids that
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display both the mechanical stability of a rigid inorganic framework and the particu-
lar reactivity (e.g., selective recognition, optical properties) of the organic component;
(b) The fact that sol-gel-derived materials can be used to encapsulate biomolecules (e.g.,
enzymes, antibodies, or other proteins) in a functional state;
(c) The discovery of the supramolecular template approach, which can generate ordered
mesostructures over long length scales.
Figure 1.4: Sol-gel formation reactions from silica based alkoxide precursors.
Surfactants are surface active agents composed of a charged or polar head group and
a hydrophobic nonpolar tail. The tail is generally a hydrocarbon chain with 6-22 carbon
atoms. The hydrophilic region of the molecule – the head group – may be positive, neg-
ative, neutral or zwitterionic, thus categorizing the surfactant as cationic, anionic, non-
ionic or zwitterionic59,60. Surfactants with longer hydrocarbon chains are also less prone
to denature proteins than short chained compounds. Zwittergents like amphoteric sulfo-
betaines are usually more inactivating than non-ionic reagents59,60. Surfactant molecules
can be adsorbed at the interface between two bulk phases such as the electrode/solu-
tion interface; lowering the interfacial tension between the two and facilitate the contact.
Therefore, these surface active agents are capable of modifying and controlling electrode
surface properties61. Surfactant molecules can aggregate to form supra-molecular struc-
tures with specific regions of hydrophilic and hydrophobic character. In aqueous solu-
tion, above the critical micellar concentration (CMC), they form spherical micelles with
the hydrophilic head groups facing the solution and the hydrocarbon chains oriented
towards the interior of the structure Figure 1.5 59. The CMC is characteristic of each sur-
factant and in addition to micelle formation it is also correlated with abrupt changes or
sharp discontinuities in the physical properties of the surfactant, such as conductivity
and surface tension62,63.
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Figure 1.5: Schematic representations of surfactants in various forms, the headgroups are
represented by the red circles and the hydrophobic tails are in blue. A) Spherical micelles,
B) hemimicelles, C) bilayers and D) multilayers on electrode surfaces39.
Electrochemistry mainly takes advantage of two properties associated with these sur-
face active agents: their ability to adsorb at interfaces and to generate membrane-like
structures61. In particular the membrane bound proteins incorporated in surfactant films
are expected to experience a more natural environment, closer to the physiological sur-
roundings they are taken from. Accordingly, surfactant films can help to promote and
enhance protein electrochemistry and catalysis. Obvious cases are membrane-bound
proteins62, such as the enzyme employed in this thesis. Various soluble proteins have
also shown enhanced electron transfer in surfactant films61,64-66. Myoglobin and some
cytochrome P450 isoforms, for example, have showed good reversible electrochemistry
in surfactant films of DDAB (Dodecyldimethylammonium bromide) at PG electrodes, as
opposed to the bare ones, where no DET was observed. According to spectroscopic stud-
ies, both proteins were also able to keep their native conformations while embedded in
the films62,63,67.
The good performance of proteins in surfactant films has been associated to the strong
adsorption of the surfactant at the electrode-film interface, therefore avoiding the de-
naturative adsorption of proteins or of other macromolecules that could block electron
transfer63. Also, the well-defined microstructure and dynamics of the surfactant films al-
lows good diffusion within the layer. These films can also help to guide the orientation of
immobilized proteins. Which may not be related with the surfactant headgroup charge
but with the interaction between the protein and the hydrophobic bilayers68.
Rusling has pioneered the use of surfactant films on carbon surfaces for direct electro-
chemistry of heme proteins69-71. The surfactant is deposited onto the electrode, resulting
in the formation of bilayers and micelles into which the protein is incorporated. The end
result is a system that supports rapid and reversible ET between the electrode and the
enzyme; typically, standard rate constants between 50 and 300 s-1 are observed. Protein-
surfactant film voltammetry is now a routine method for studying the redox chemistry of
12
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Heme transfer proteins: flavocytochromes72, engineered mutants73, as well as bacterial74
and mammalian75 variants, have been investigated.
1.1.5 Amperometric biosensors
As previously mentioned, a biosensor is generally defined as a sensing device consisting
of a biological recognition element in intimate contact with a suitable transducer which is
able to convert the biological recognition reaction, or eventually the biocatalytic process,
into a measurable electronic signal. In the particular case of an amperometric sensor,
the redox species in the sensing layer are oxidized or reduced at the transducer surface
generating a current through the electrode. Assuming an enzyme catalyzed oxidation of
a substrate (e.g. glucose, lactate, alcohol, etc.), either a prosthetic group integrated within
the enzyme (e.g. FAD, PQQ, heme, transition metals) or a co-substrate (e.g. FMN, NAD+,
NADP+) has to be reduced, intermediately storing the transferred redox equivalents. A
measurable current through the electrode is related to the re-oxidation of the prosthetic
group or the co-substrate in order to regenerate the enzyme and make it available for
further substrate recognition and conversion reactions. Hence, a signal is only obtained
if the transfer of electrons between the intermediately reduced enzyme (i.e. the prosthetic
group or the co-substrate) and the electrode is possible. From this discussion it is evident
that the specific features of the biosensor are highly dependent on the kinetics of this
electron transfer process. Consequently, an essential prerequisite for the development
of amperometric biosensors with high sensitivity and fast response characteristics is to
establish a fast electron transfer (ET) from the biological component to the electrode.
1.1.5.1 Electron transfer
At a first glance, the easiest ET mechanism in an amperometric biosensor would be the
direct electrochemical recycling of the enzyme’s prosthetic group at the electrode sur-
face involving electron tunneling mechanisms (Figure 1.6). However, according to the
Marcus theory76, the ET kinetics between two redox species is determined by the driving
force (i.e. the potential difference), the reorganization energy (which qualitatively reflects
the structural rigidity of the redox species) and the distance between the two redox cen-
ters. Obviously, the ET distance between the prosthetic group and the electrode surface
is rather long due to the shielding by the protein shell, and direct ET via a tunneling
mechanism is therefore rarely encountered.
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Figure 1.6: Direct ET (tunneling mechanism) from the active site of an enzyme to the
electrode surface77.
Thus, the main aim in the design of optimized amperometric biosensors is to en-
sure fast ET processes based on electrode architectures with predefined ET pathways
interconnecting the redox site within the enzyme and the electrode surface. The elec-
tron transfer in biology usually involves initial protein-protein complex formation based
on the complementarity of the docking sites. Efficient protein-electrode reactions ap-
pear to have some similarities to the way in which proteins act with their natural redox
partner78. Therefore, methods for chemically modifying electrode surfaces as to mimic
the biological situation were developed. The heterogeneous electron transfer between
proteins and electrodes may be coupled with other reactions where the proteins act as
vectorial mediators79,80.
The principle of direct electrochemistry of redox proteins, can be explained by com-
paring this technique to the more traditional solution essays of enzyme activity. In homo-
geneous enzyme kinetics, the enzyme may be mixed in a cuvette with its substrate and
a redox partner (otherwise called a mediator or co-substrate), providing a source/sink of
electrons for the redox transformation of the substrate and whose absorbance depends
on its redox state. In the steady state, the rates of substrate and co-substrate transforma-
tions are equal to the turnover rate of the enzyme and can therefore be determined by
following the absorbance change of the solution81.
In direct electron transfer (DET) the increase in catalytic currents is a result of the en-
zyme’s cofactors direct regeneration (Figure 1.7A). This type of communication with the
electrode, is typically harder to achieve due to the insulating nature of protein polypep-
tide chains and the location of redox centers, which are commonly deeply buried within
the protein structure. Furthermore, the protein molecules can have an unfavorable ori-
entation on the transducer surface, sometimes contributing to an increased distance be-
tween the electroactive centers and the electron transfer partner (the electrode) and thus
hindering the electron exchange39.
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Figure 1.7: Schematic representations of the working principles of enzymatic biosensors
with a reductase as biologic component: A)Mediated transduction, B) Direct transduc-
tion. (medox – mediator in the oxidized form; medred –mediator in the reduced form;
enzymeox – reductase oxidized state; enzymered – Reductase reduced state).
Nowadays is still common to think that oxireductases are too large and too fragile to
interact directly with a solid electrode without being at least partly denaturated. It is usu-
ally held that because the active site of these enzymes is deeply buried in the protective
protein matrix, direct electron exchange at an electrode can only occur under exceptional
conditions. However, more than 20 years have passed since it was shown that direct
electron transfer (DET) can occur between an electrode and a large, catalytically active
enzyme,82,93 and about one hundred examples have already been reported81,94.
Unlike in DET, the use of redox mediators takes control over the protein reaction cen-
ter away from the electrode95(Figure 1.7B). On the one hand, this can be detrimental to the
selectivity of detection, because the mediator can react with other species present, and,
for biosensors, can require a more complex manufacturing process, additional reagents,
and sophisticated immobilization methods. On the other hand, redox mediation can
overcome the frequently sluggish electron communication of enzyme redox centers with
electrodes, thus increasing ET rates96. Mediated transfer of redox equivalents is the work-
ing principle of second-generation amperometric biosensors. Mediators are character-
ized by having a high heterogeneous ET rate that does not compromise electrochemical
reversibility and, at the same time, homogeneous, rapid electron exchange with the en-
zyme. Both oxidized and reduced forms of the mediator should be stable and unreactive
with oxygen; also, the reaction should not depend on pH. Furthermore, when select-
ing a redox mediator for biosensor applications it is important to consider toxicity, bio-
compatibility, ease of immobilization, and, very importantly, the redox potentials. Low
operating potentials are preferred, enabling appropriate enzyme reaction transduction
while avoiding side reactions. In other words, a mediator should shift redox potentials
from the extreme values necessary to detect target analytes, to values near zero, at which
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fewer interfering species are reduced or oxidized95,97,98. In mediated electrochemistry,
the consumption of the redox partner is detected as a current wave resulting from its
electrochemical recycling on the electrode; only the mediator interacts with the electrode,
and the homogeneous catalytic process which occurs in the bulk of the electrochemical
cell is fundamentally the same as that in solution assays81.
Biosensors can be grouped into generations according to the modes of signal trans-
fer between a redox enzyme and an electrode, i.e., via the natural secondary substrates
or products of the enzyme reaction (first generation), via artificial (either synthetic or
biological) electron mediators (second generation) or via direct electronic contact (third
generation)34,99,100. A typical first generation biosensor is a glucose sensor with gel en-
trapped glucose oxidase on a Clark-type electrode101,102 and also many variants of cou-
pled enzymes on oxygen-sensitive electrodes103.
Table 1.4: Generations of enzyme based amperometric and voltammetric biosensors MET,
mediated electron transfer; DET, direct electron transfer96.
1.2 Nitrite Reductase based electrochemical biosensor
1.2.1 Nitrite assessment
Nitrate (NO−3 ) and nitrite (NO
−
2 ) are rarely found without each other, because their chemistries
are practically indissociable.
Nitrate occurs naturally in soils containing nitrogen-fixing bacteria, decaying plants,
septic system effluents, and animal manure. Among the artificial sources of nitrate there
are nitrogenous fertilizers and airborne nitrogen compounds emitted by industry and
motor vehicles. Nitrate penetrates through the soil and remains in groundwater for
decades104; groundwater is the source for >50% of drinking water supplies, 96% of pri-
vate water supplies, and an estimated 39% of public water supplies105.
Water containing a high concentration of nitrite can create serious problems, for ex-
ample, eutrophication of aquatic systems and potential hazards to human health106. The
eutrophication in rivers, lakes, and coastal waters has become one of the most prevalent
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environmental problems in recent years106,107. The health implications of exposure to ni-
trate in drinking water were first reported in 1945 by Comly after observing cyanosis in
infants in Iowa, where well water was used in formula preparation108. These implica-
tions made it so that nitrite has been considered an important toxic agent109. However,
as of late, there have been many new findings that imply the nitrite’s role in the human
organism may not be so straightforward, the main controversy is that nitrite’s ingestion
might be beneficial for human health despite it’s being considered solely hazardous since
the 1940’s110-122.
In order to manage environmental and health risks, deriving from exposure to these
ions, governmental agencies have implemented rules and directives to restrict the levels
of NO−3 and NO
−
2 in drinking waters and food products. European directive 98/83/EC
has established the maximum admissible levels of nitrate and nitrite in drinking water
at 50 and 0.1 ppm, respectively. Likewise, the World Health Organization has set these
limits at 50 ppm (NO−3 ) and 3 ppm (NO
−
2 ) (WHO/SDE/WSH/07.01/16). More recently,
following the European Food Safety Authority recommendations, 2006/52/EC directive
has reduced the authorized levels for these ions in meat and other food products, which
should be controlled on the basis of added rather than residual amounts (e.g. 150 mg/kg
of nitrites in meat products). Furthermore, the determination of nitrite in human physio-
logical fluids is also commonly used for clinical diagnosis. As a result, there is a growing
demand to detect nitrite in food, drinking water and environmental samples123.
1.2.2 Nitrite Biosensors
In the last decades, biosensor technology has been exploited as a route to provide reliable
nitrite quantification in complex samples. Hence, several protein electrodes and optical
devices are described in the literature2,34,39,124-130.
When it comes to nitrite biosensors, the bulk of the approaches make use of mediated
electron transfer by employing redox mediators (e.g. viologen derivates) that display a
fast and reversible electrochemical response and are able to shuttle electrons rapidly to
the redox centers of the proteins39.
As transducing modes one could find a vast predominance of electrochemical ap-
proaches, the largest group being the voltammetric and/or amperometric ones and a
small number being based on potentiometric or conductimetric platforms. Alternatively,
the spectroscopic changes that take place during the catalytic cycle were also employed
in the construction of optical biosensors. The strategies proposed for protein immobiliza-
tion have relied on a variety of materials, ranging from non-conducting polymers, elec-
tropolymerized films, redox active clays, sol-gel silica glasses, carbon nanotubes, metal
nanoparticles and DNA tethers, either alone or in composite formulations. Although the
construction of these sensing devices is far from trivial, major progresses have been made
over the last decade. After the preliminary studies carried out using non-immobilized
electron carrier species, fully integrated biosensors based on mediated electrochemistry
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have become a common configuration. More advanced strategies operating in the un-
mediated mode via DET131 and exploiting nanostructured materials as electrodes inter-
faces were recently proposed35. In parallel, stability has been substantially improved
through the construction of leak free devices and the use of protecting coats. Very re-
cently, the screen printing technology was successfully employed, opening up the route
for miniaturization132.
The less used, mediatorless approaches - the ones on which this thesis will focus -
are based on the direct electron transfer between the nitrite reductases and the electrode
material.
Table 1.5 summarizes some of the most recent and representative works done in the
field. A detailed analysis of this table clearly demonstrates that although electrode mod-
ifications are made with all sorts of materials, combined with polymers, silicates, surfac-
tants or ionic liquids, the systems share many common features. Direct electron transfer
between proteins and electrodes is frequently promoted by the modifying matrix and the
intensity of the catalytic currents is correlated with nitrite concentration; amperometric
transduction is a frequent option; and the working electrodes are always made of carbon
materials (usually, glassy carbon (GC)).
Overall, the tabulated analytical parameters were highly variable. For instance, the
detection limit can be as low as 0.06 µM and go up to 700 µM. Though, the substrate
promiscuity of all these heme containing proteins puts in risk the selectivity of determi-
nation, so they are not recommended for the construction of a selective nitrite biosensor.
Instead, much more selective biocatalysts should be employed. The next section aims to
describe all nitrite biosensing systems reported hitherto that make use of highly selective
enzymes for nitrite reduction.
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1.2.3 Nitrite reductases
Nitrite reducing enzymes (NiRs) are the natural candidates for playing the role of biorecog-
nition element in the nitrite biosensing devices. Four classes of NiRs have been recog-
nized so far (Figure 1.8), all of which have already been used in biosensor applications.
They can be grouped according to the type of co-factors and reaction product133,134.
Figure 1.8: Three-dimensional structures of nitrite reductases. (a) Desulfovibrio vulgaris
Hildenborough multiheme c nitrite reductase (NrfA4NrfH2 complex); the catalytic sub-
unit (NrfA) is depicted in blue and the electron donor subunit (NrfH) in gray; heme
groups are shown in dark red. (b) Spinach nitrite reductase; siroheme is shown in dark
red and iron-sulfur cluster in yellow. (c) Achromobacter cycloclastes copper nitrite re-
ductase (trimer); the copper centres are shown in blue. (d) Pseudomonas aeruginosa
cytochrome cd1 nitrite reductase (dimer); heme c is depicted in dark red and heme d in
blue125.
There are two types of ammonia forming nitrite reductases: cytochrome c nitrite re-
ductases (ccNiRs), which are multi-heme enzymes isolated from sulfate or sulfur reduc-
ing bacteria, and sirohemic nitrite reductases, which contain a siroheme and an iron-
sulfur cluster and are commonly purified from photosynthetic organisms such as plants,
algae and cyanobacteria. This group of enzymes is able to catalyze the six electron reduc-
tion of nitrite to ammonia, according to the following equation:
NO−2 + 8H
+ + 6e− → NH+4 + 2H2O (1.2)
The nitric oxide forming nitrite reductases are dissimilatory NiRs involved in bacte-
rial denitrification; they catalyze the one electron reduction of nitrite to nitric oxide.
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NO−2 + 2H
+ + e− → NO +H2O (1.3)
There are two different types: the copper-containing nitrite reductases (CuNiRs), with
type-I and type- II copper centers, and the cytochrome cd1 nitrite reductases (cd1NiRs)
that comprise a c-type and a d1-type heme134.
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Table 1-5 Description and analytical parameters of nitrite reductase based biosensors (N.A. —not applicable; N.D.—not determined; 
Enzyme Source Sensor preparation Transducing mode Electron transfer Linear Range 
Detection 
Limit 
Sensitivity Reference 
Sirohemic 
NiR  
Spinach leafs enzyme + BSA + glutaraldehyde Potentiometric N.A. 0.1–50 mM N.D. N.D. 135 
ccNiR D. desulfuricans 
GC/casting of enzyme + polyacrylamide 
(mediator in solution) 
Voltammetric 
MET 
 (methyl viologen) 
up to 200 µM N.D. N.D. 
136 
ccNiR D. desulfuricans GC/casting of enzyme + polyacrilamide DET up to 200 µM N.D. N.D. 
ccNiR D. desulfuricans 
GC/dispersion of poly(pyrrole-viologen) 
+ enzyme mixture followed by 
electropolymerization 
Voltammetric 
MET  
(poly(pyrrole-
viologen)) 
5.4–43.4 µM 5.4 µM 1,721 mA M−1cm−2 128 
ccNiR D. desulfuricans 
GC/casting of Nafion + enzyme/ 
incorporation of 
mediator  
Voltammetric 
MET  
(methyl viologen) 
75–800 µM 60 µM 445 mA M−1cm−2 130 
ccNiR D. desulfuricans 
GC/casting of [ZnCr-AQS] LHD + 
enzyme/ glutaraldehyde vapor cross-
linking 
Amperometric 
MET 
 (AQS) 
0.015–2.350 
µM 
4 nM 1,824 mA M−1cm−2 132 
ccNiR D. desulfuricans 
gold/casting of Nafion + enzyme + 
mediator + glycerol + BSA/ 
glutaraldehyde vapor cross-linking 
Conductimetric 
MET 
 (methyl viologen) 
0.2–120 µM 0.05 µM 0.194 µS/µM 137 
ccNiR D. desulfuricans 
pyrolytic graphite/casting of EETMS sol/ 
casting of enzyme 
Amperometric DET 0.25–50 µM 120 nM 430 mA M−1cm−2 124 
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ccNiR D. desulfuricans 
graphite/casting of SWCNTs 
dispersion/casting of enzyme 
Voltammetric DET up to 150 µM N.D. 2,400 mA M−1cm−2 138 
ccNiR S. deleyianum 
graphite and mediator composite/casting 
of enzyme + poly(carbamoyl sulfonate) 
hydrogel membrane 
Amperometric MET (phenosafranin) up to 250 µM 1 µM 446.5 mA M−1cm−2 139 
cd1NiR P. denitrificans  
graphite/enzyme entrapment through 
dialysis membrane 
(mediator in solution) 
Amperometric  
MET 
(1-methoxy PMS) 
4.35–65.2 
µM* 
N.D. N.D. 140 
cd1NiR P. denitrificans  
graphite/enzyme entrapment with dialysis 
membrane 
(mediator in solution) 
Amperometric 
MET 
(1-methoxy PMS) 
up to 750 µM 10 µM 33 mA M−1cm−2 139 
cd1NiR P. pantotrophus 
enzyme incorporated in bulk sol-gel 
monoliths of TEOS 
Optical N.A. 
0.075–1.250 
µM 
0.075 µM N.D. 141 
cd1NiR P. pantotrophus 
enzyme in controlled pore glass beads of 
isothiocyanate 
Optical N.A. 0–4 mM 0.93 µM 19.5 nM−1 142 
cd1NiR 
M. hydrocarbono-
clausticus 
graphite/casting of polyvinyl alcohol + 
enzyme + mediator followed by 
photopolymerization 
Amperometric 
MET  
(cyt-c552) 
10–200 µM 7 µM 2.49 A cm2 µM−1 129 
CuNiR R. sphaeroides  
GC/electropolimerization of PPB/ casting 
of enzyme + PBV 
Voltammetric MET (PPB) up to 50 µM 1 µM 789 mA M−1cm−2* 143 
CuNiR R. sphaeroides  
GC/casting of poly(vinyl alcohol) + 
mediator + enzyme/ casting of 
poly(allylamine hydrochloride)/ 
casting of hydrophilic polyurethane 
Amperometric 
MET 
 (methyl viologen) 
1.5–  1.5 µM 170 mA M−1cm−2* 144 
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CuNiR A. faecalis 
gold/enzyme entrapped with dialysis 
membrane 
(mediator in solution) 
Amperometric 
MET  
(1-methoxy PMS) 
0–22 µM* 0.22 µM* N.D. 145 
CuNiR A. faecalis 
gold/dip-coating in (cysteine) thiolated 
hexapeptide 
(enzyme and mediator in solution)  
Voltammetric 
MET (pseudoazurine) 
200–1,500 
µM  
N.D. N.D. 
146 
gold/dip-coating in (cysteine) thiolated 
hexapeptide 
(enzyme and mediator in solution)  
MET (ruthenium 
hexamine) 
1–100 µM N.D. N.D. 
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1.2.3.1 Cytochrome c Nitrite Reductase
The cytochrome c nitrite reductase from D. desulfuricans was used as biorecognition ele-
ment, in the experiments addressed in this thesis. This enzyme is involved in the path-
way of dissimilatory nitrite reduction to ammonia thereby playing a crucial role in the
biogeochemichal nitrogen cycle.
As mentioned above, ccNiR catalyzes the six-electron reduction of nitrite to ammonia
(NH+4 ) using electrons from the oxidation of formate or hydrogen, mediated through a
menaquinone and a quinol- oxydizing system147.
ccNiR also catalyzes the reduction of nitrite oxide and hydroxylamine to ammonia
and of sulfite to sulfide It is usually found as a membrane associated complex with a
transmembrane subunit. The physiological form of the enzyme is believed to be a dou-
ble trimer of 2 NrfA and 1 NrfH subunits148 (Figure 1.9) in vitro, the protein complexes
associate each other forming large aggregates (min. 890 kDa)149.
Periplasm
Cytoplasm
Figure 1.9: Secondary structure of NrfHA viewed parallel to the membrane (grey rectan-
gle) with haems drawn as red sticks148.
The catalytic subunit NrfA (61 kDa), which is associated to the periplasmic mem-
brane, is a pentaheme cytochrome c-type where the short distances between hemes allow
a fast and efficient electron transfer150,151. It can be assessed by two channels that reach
the protein surface.
They were proposed to be the substrate and product channels because they have an
overall electrostatic charge opposed to the anion NO−2 substrate and cation NH
+
4 product
that should flow through them. This is thought to contribute to the high catalytic activity
of this enzyme151-153 . The product channel in D.desulfuricans ccNiR is partially blocked
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by a polypeptide segment; accordingly, the product may have to find a different route
to exit the active site or a conformational change may allow this to occur through the
designated product channel151. NrfH (19 kDa) is a small membrane-bound cytochrome
comprising four c-type heme groups and it serves a double purpose; it anchors the cat-
alytic subunits to the membrane and serves as a quinol oxidase, transferring electrons
from the quinone pool to the catalytic subunits148,149. It is composed of a transmembrane
helix and a globular hydrophilic domain that houses the four hemes. The NrfH subunit
interacts with the NrfA dimmer in an asymmetrical way, with only one of the catalytic
monomers receiving electrons directly from NrfH.
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1.3 Cytochrome P450 based biosensors
1.3.1 Cytochromes P450
he cytochromes P450b (CYP) are a ubiquitous superfamily of mixed function oxidases.
They play an important role in the detoxication of bioactive compounds and hydrophilic
xenobiotics being formed inside cells in living organisms (cholesterol, saturated and
unsaturated fatty acids, steroids, prostaglandins and others) or from external souces
(medicines, drugs, food supplements, and environmental pollutants)166,167. These en-
zymes represent a superfamily of b-type hemeproteins with a catalytic activity towards
two substrates: oxygen and organic substances The general monooxigenase reaction by
which the CYPs metabolize their substrates is the following.
RH +O2 +NA(P )H +H
+ → ROH +H2O +NAD(P )H+ (1.4)
The generic reaction catalyzed by P450 (Figure 1.11) implies the reduction of molecu-
lar oxygen with two electrons that are supplied by various redox partners168.
Figure 1.10: Proposed Cyt P450 Catalytic Cycle. RH: lipophilic compound in which an
oxygen atom derived from O2 is introduced.
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These enzymes are unique in being able to hydroxylate non activated carbon atoms
(C-H bonds)156,166,167. The products of substrates’ metabolism usually serve as regu-
lators in cells or are excreted from organisms. Cytochromes P450 are capable of metab-
olizing over 1,000,000 chemicals and involve about 60 distinct classes of biotransforma-
tion reactions, e.g. hydroxylation, N-, O- or S-demethylation, dealkylation, epoxydation
among others169,170. This particular feature of P450s makes them one of the most studied
proteins as they are highly promising for use in farmaceutical drug assays and in stereo-
directed synthesis of steroids171. For eukaryotic microsomal P450, the membrane-bound
form of NADPH cytochrome P450 reductase (CPR) is the primary source of electrons168.
Electrons from NAD(P)H flavins ferric form of cytochrome P450 (Fe3+). Resting P450s
are in the ferric form (Fe+3 ), one electron reduction of ferric form leads to ferrous state
(Fe+2 ) of hemoprotein, which can bind oxygen
172. During reduction of P450s according to
the scheme Fe+3 +e
− → Fe+2 NADPH or NADH are exhausted159. The P450s share a com-
mon fold that is unique to this enzyme class. P450s are mainly β-helical, with the heme
cofactor sandwiched between a larger helix-rich (alpha) domain and a small β-sheet-rich
(beta) domain. A core structure around the heme cofactor provides the scaffold that al-
lows oxygen activation by the P450s. The heme iron is equatorially coordinated by four
pyrrole nitrogens from the heme b macrocycle, and axially coordinated by a conserved
cysteine as the proximal ligand and typically by a water molecule as the distal ligand (in
the P450 resting state).
1.3.2 NADPH-cytochrome P450 reductase
As previously mentioned, for eukaryotic microsomal P450s, the membrane bound form
of cytochrome P450 reductase (CPR) orchestrates the stepwise electron transfer from
NADPH to the cytochrome P450 heme center168,173,174. NADPH-cytochrome P450 oxi-
doreductase transfers electrons from NADPH to cytochrome P450 and catalyzes the one-
electron reduction of many drugs and foreign compounds. CPR is a 78 kDa membrane
anchored multidomain enzyme composed of a FMN-containing flavodoxin like domain
associated with a FAD-containing ferrodoxin reductase like domain175 probably origi-
nating from horizontal gene transfer or exon fusion. A folded connecting domain joins
the two sections. By using its two flavin cofactors and a peculiar electron transfer cycle,
CPR is able to split the dielectronic flux of NADPH by sequential electron transfer to
external acceptors176.
Electron transfer in biological systems occurs in the presence of electron donors such
as NADPH and NADP, and is generally affected by electron transfer mediators, such
as flavin nucleotides. In the presence of substrate and dioxygen, the monooxygenation
reaction of the CPR-CYP enzyme system is dependent on the binding of NADPH to CPR.
Electrons, in the form of a hydride anion are transferred from NADPH to FAD. Reduced
FAD then transfers single electrons to FMN, which in turn reduces the prostetic heme
iron of the CYP178,179.
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Figure 1.11: Model of the conformational equilibrium in CPR177.
1.3.3 Cytochrome P450 1A2
Human CYP1A2 is one of the major CYPs in human liver; it metabolizes a variety of clin-
ically important drugs (e.g., clozapine, tacrine, tizanidine, and theophylline), a number
of procarcinogens (e.g. benzo[a]pyrene and aflatoxin B1), and several important endoge-
nous compounds (e.g. steroids and arachidonic acids). Like many other CYPs, CYP1A2
is subject to induction and inhibition by a number of compounds, which may provide
an explanation for some drug interactions observed in clinical practice. A large inter-
individual variability has been observed in the expression and activity and in the elimi-
nation of drugs that are mainly metabolized by CYP1A2. This is largely caused by genetic
(e.g., Single-nucleotide polymorphisms) and epigenetic (e.g., DNA methylation) and en-
vironmental factors (e.g., smoking and comedication). CYP1A2 is primarily regulated by
the aromatic hydrocarbon receptor (AhR). It is induced through AhR-mediated transacti-
vation following ligand binding and nuclear translocation. To date, more than 15 variant
alleles and a series of subvariants of the CYP1A2 gene have been identified and some of
them have been associated with altered drug clearance and response to drug therapy180.
1.3.4 P450 based electrochemical Biosensors
Investigation of the catalytic activity of isolated cytochromes from the P450 superfamily
requires the obligatory presence of redox partners and electron donors (NADPH) (see
section 1.3.3). However, redox partners are not obligatory for the electrochemical reduc-
tion of P450 family hemoproteins, so the catalytic system is essentially simplified. The
electrochemical approach is especially important in the case of unknown physiological
partners (e.g. CYP51 MT, systematic name CYP51b1)154. Electrochemical systems exe-
cute a dual function: substitute partner proteins and serve as a source of electrons for
redox enzymes. Electrochemistry permits to study the whole catalytic cycle of P450s
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Figure 1.12: The secondary and tertiary structure of human P450 1A2 is shown in two
views. The α-helices are colored blue, and the β-strands are colored brown. These sec-
ondary structure elements are designated A-L and 1-4, respectively, and are sequentially
identified from the N terminus. The heme prosthetic group is represented in sticks and
is colored red. The substrate binding cavity is illustrated as a red mesh surface.
from different viewpoints. On the one hand, the enzyme P450-electrodes are power tools
for investigation of the catalytic properties of P450s towards new chemicals (i.e. for the
search of new drugs with the properties of substrates or inhibitors). On the other hand,
the stoichiometry of the P450’s catalytic cycle and the thermodynamics of electrochem-
ical reduction of P450s can also be assessed. Additionally, electrochemistry can allow
the investigation of the peroxide shunt pathway with the help of bifunctional electrodes,
therefore permitting the direct registration of hydrogen peroxide consumption by the
hemeprotein155.
As mentioned above P450 enzyme electrodes aim to eliminate the complex electron
transfer machinery of the P450-reductase required in nature. For their successful elec-
trochemical response two points must be addressed. First of all, the enzyme should be
in its native conformational state and retain its catalytic activity after the adsorption or
immobilization procedure, i.e. it should maintain its active P450 form and not convert
to the inactive P420 one. The P420 form results from the weakening or distortion of the
thiolate bond of the cysteine residue that is the fifth ligand of the heme156. This bond
weakening can occur upon immobilization on electrode surfaces. Secondly, care must be
taken on the coupling of the electron consumption that must be linked to the conversion
of the substrate into its product(s). The fine-tuning of electron delivery and proton flow is
crucial for the efficient conversion of substrate to product by cytochrome P450 enzymes.
Ideally all the electrons provided by the electrode should be used in the formation of
the product and not wasted on the production of oxygen reactive species in uncoupled
reactions. Unfortunately this phenomenon does occur and it is well-documented for the
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human drug metabolizing P450 enzymes157: oxygen and NAD(P)H are largely used by
these enzymes to produce hydrogen peroxide and superoxide anion radical or water.
The relevance of such an approach is obvious: cytochrome P450 and P450-based en-
zyme electrodes may be used as biosensors in patient-tailored (personalized) medicine,
high- throughput screening and drug interference studies.The biotechnological interest
related to these enzymes in the development of biocatalysts or biosensors158-160 is due
to their versatility in the recognition of a vast array of compounds, many of which are
relevant to the development of fine chemicals, new drugs and drug products and even
environmentally important compounds (detected or degraded through bioremediation).
However, in spite of the huge biotechnological interest, their use in bioelectrochemical
devices has proven to be highly challenging.
The progression of P450-electrode systems into amperometric biosensors is largely
dependent on the efficiency of the electrode-driven P450 activity and therefore the im-
mobilization. Which is why a large part of this work is centered on immobilization
strategies. However, there are two technical difficulties in handling P450s based elec-
trochemical biosensors. The first problem is the complexity in the measurement of their
enzymatic activity.
Most P450s need another redox protein as an electron donor for their activity be-
sides the lipophilic substrate, O2 and NADPH or NADH. Pathways of electron transfer
to P450s are shown in Figure 1.10.
NADPH
FMNHeme
ROHRH
FADO2
P450 P450 reductase
Figure 1.13: schematic representation of electron transfer in microsomal membrane. Elec-
tron transfer from P450 reductase to P450 (adapted from Hara (2000).161).
For example, P450 reductase transfers electron to microsomal type P450 as shown in
the scheme in Figure 1.10. Usually, two electrons are supplied from NADPH to P450
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through P450 reductase containing both FAD and FMN as shown in the upper part of
this scheme.
Kinetic parameters such as Michaelis constant (KM) of the substrate highly depend
on the microenvironment of the lipid membrane on which the P450 is bound. Both iso-
lated P450 and P450 reductase should be coreconstituted into the same liposomes for
expressing its full enzymatic activity.
The second problem is the stability of the enzyme. Many P450s, especially membrane-
bound enzymes from microsomes or mitochondria are labile. Some can be partly stabi-
lized in the presence of glycerol161.
The types of electrode modifications used in CYP biosensor studies vary, as shown
in Table 1.6, ranging from thin films with opposite charge adsorbed onto graphite to
conductive polymers deposited onto noble metals such as gold or platinum. Most of
these studies rely on a combination of electrochemical and analytical techniques to show
that the CYP biosensor is electroactive and can detect different drug compounds via
electrochemically-driven catalysis. Nevertheless, a number of recent studies character-
izing the active site structure and redox potential of CYPs immobilized on electrodes
have shown that much of the CYP immobilized on the electrode is in an inactive form
and call into question the results from previous CYP biosensor studies162-164.
In addition, some CYP biosensor studies are missing crucial substrate turnover data
and instead rely on electrochemical experiments alone to indicate that the immobilized
CYP is capable of electrochemically- driven catalysis157.
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Table 1-6 Summary of different electrode types and electrode modifications used to construct CYP electrodes and biosensors 165. 
CYP enzyme    Electrode material    Electrode modification    Result    Reference 
Adsorption to bare electrodes 
CYP101 (P450CAM)   Edge-Plane Pyrolytic 
Graphite 
None Reversible peaks for FeIII/FeII seen in anaerobic CV 
Increased reduction peak area in presence of  D-(þ )-
camphor 
Kazlauskaite et al., 1996 
CYP101 Mutant SCF-
K344C 
Gold None Enhanced electroactivity of the SCF-K344C mutant Lo et al., 1999 
CYP2E1 Gold None Reversible peaks for FeIII/FeII seen in anaerobic CV, 
ks=5 s-1 
Fantuzzi et al., 2004 
CYP199A2 Basal-Plane Pyrolytic 
Graphite 
None Quasi-reversible peaks for FeIII/FeII seen in anaerobic 
CV, ks=550 s-1 
Fleming et al., 2007 
CYP101 Glassy Carbon None Increased reduction peak area in presence of D- (þ )-
camphor, ks=0.016 s-1 
Mhaske et al., 2010 
Layer-by-Layer Adsorption 
CYP101 Gold Multilayer films of PSS and PDDA 
on an MPS SAM 
Reversible peaks for FeIII/FeII seen in anaerobic CV 
Electrochemically-driven styrene epoxidation 
(turnover 9.3 h-1) 
Lvov et al., 1998 
CYP3A4 Gold MPS SAM followed by PDDA Reversible peaks for FeIII/FeII seen in anaerobic CV 
Electrochemical detection of the 3A4 substrates 
verapamil and midazolam 
Joseph et al., 2003 
CYP1A2 Carbon Cloth Alternate adsorption of PSS and 1A2 Reversible peaks for FeIII/FeII seen in anaerobic CV 
Electrochemically-driven styrene epoxidation 
(turnover 39 h-1) 
Estavillo et al., 2003 
CYP1A2 and CYP3A4 
microsomes 
Pyrolytic Graphite Multilayer films of PEI and PSS Reversible peaks for FeIII/FeII seen in anaerobic CV 
Electrochemically-driven styrene epoxidation 
Sultana et al., 2005 
CYP1A2 and CYP2E1 Basal-Plane Pyrolytic 
Graphite 
Multilayer films of CYP and CPR/b5 Reversible reduction and oxidation peaks visible in 
anaerobic CV 
Krishnan et al., 2011 
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Evidence that electron transfer follows natural 
catalytic pathway from CPR 
Electrochemically-driven catalysis of NNK to HPB  
by 2E1 electrode 
Adsorption to Thin Films 
CYP101 Glassy Carbon Pretreated sodium montmorillonite 
clay colloid 
Reversible peaks for FeIII/FeII seen in anaerobic CV 
Fast electron transfer (5 to 152 s-1 for scan rates of 0.4 
to 12 V/s) 
Lei et al.,2000 
CYP2B4 Glassy Carbon Mixture of sodium montmorillonite 
clay colloid, 2B4, and Tween 80 
Reversible peaks for FeIII/FeII seen in anaerobic CV 
Amperometric detection of the 2B4 substrates 
aminopyrine and benzphetamine 
Shumyantseva etal., 2004 
CYP101 Pyrolytic Graphite DDAB or DMPC Reversible peaks for FeIII/FeII seen in anaerobic CV 
Relatively fast electron transfer with DDAB (ks=26 s-
1) and DMPC (ks=25 s-1) 
Zhang etal.,1997 
CYP2C9, 2C18, and 
2C19 
Edge-Plane Pyrolytic 
Graphite 
DDAB Reversible peaks for FeIII/FeII seen in anaerobic CV 
for all three enzymes Weak signal-to-background 
current and only 1–3% of enzyme is electroactive 
Shukla etal.,2005 
CYP2C9 Edge-Plane Pyrolytic 
Graphite 
DDAB Reversible peaks for FeIII/FeII seen in anaerobic CV 
Anodic shift in redox potential with 2C9 substrates 
torsemide, warfarin, and tolbutamide and with CO 
Johnson etal.,2005 
CYP27B1 Edge-Plane Pyrolytic 
Graphite 
DDAB Reversible peaks for FeIII/FeII seen in anaerobic CV 
(ks=3.5 s-1) 
Rhieu etal.,2009 
No product formation observed during electrolysis 
with 27B1 substrate 25(OH)D3 
CYP3A4 fusion protein Glassy Carbon PDDA Electrochemically-driven catalysis with the 3A4 
substrate erythromycin 
Dodhia etal.,2008 
CYP101 Glassy Carbon Covalent attachment to thin film of 
pyrene maleimide 
Increased reduction peak area in the presence of D-(þ 
)-camphor 
Mhaske etal.,2010 
Screen-Printed Electrodes  
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Riboflavin-conjugated 
CYP1A2, 2B4, and 11A1 
Rhodium-graphite Mixture of CYP, BSA, 
glutaraldehyde, sodium cholate, and 
phospholipid 
Electrochemically-driven catalysis with respective 
1A2, 2B4, and 11A1 susbstrates 
Shumyantseva etal., 2001 
Amperometric detection of the substrates aminopyrine 
(2B4) and cholesterol (11A1) 
CYP1A2 Riboflavin-graphite Glycerol and agarose Amperometric detection of the 1A2 substrate 
clozapine 
Antonini etal.,2003 
CYP11A1 Rhodium-graphite Gold nanoparticles Amperometric detection of the 11A1 substrate 
cholesterol Enhanced electroactivity and sensitivity 
with inclusion of gold nanoparticles 
Shumyantseva etal., 2005 
CYP2B4 Carbon Covalent attachment via EDC/NHS 
to a COOH-functionalized electrode 
Amperometric detection of the 2B4 substrate cocaine 
in confiscated cocaine samples 
Asturias-Arribas et al.,2011 
CYP1A2, 2B4, and 51b1 Graphite Mixture of gold nanoparticles and 
DDAB 
Increased reduction peak area in the presence of 
substrates for 2B4 (benzphetamine) and 
51b1(lanosterol) Enhanced electroactivity with 
inclusion of goldnanoparticles 
Shumyantseva etal., 2007 
CYP2B4 Graphite Mixture of gold nanoparticles and 
DDAB 
Electrochemically-driven catalysis with 
benzphetamine exhibits similar uncoupling behavior 
to catalysis with 2B4 in solution 
Rudakov etal.,2008 
CYP2B4, 3A4, 11A1, 
51b1 
Graphite Mixture of gold nanoparticles and 
DDAB 
Amperometric detection of multiple substrates and 
inhibitors 
Shumyantseva et al., 2011 
Encapsulation in Polymers of Gels  
CYP101 IndiumTinOxide Polypyrrole Electrochemically-driven catalysis with D-(þ)-
camphor 
Sugihara et al.,1998 
CYP102 (P450BM3) 
Mutant 
Platinum and Glassy Carbon Polypyrrole Compared chemical vs. Electrochemical 
polymerization of polypyrrole for effect on enzyme 
catalysis 
Holtmann et al., 2009 
CYP2B4 Gold Polypyrrole Amperometric detection of the 2B4 substrate 
phenobarbitol 
Alonso-Lomillo et al.,2008 
CYP101 Glassy Carbon Methyltriethoxysilane sol-gel and 
DDAB 
Reversible peaks for FeIII/FeII seen in anaerobic CV 
in aqueous and organic media 
Iwuoha et al.,2000 
 Amperometric detection of camphor and pyrene 
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CYP2B6 Glassy Carbon Mixture of chitosan and gold Enhanced electroactivity within clusion of chitosan 
and goldnanoparticles 
Liu etal.,2008 
 Electrochemically-driven catalys is of the 2B6 
substrate bupropion 
Covalent Attachment to Self-Assembled Monolayers on Gold  
CYP2C9 Gold Amine coupling via EDC/NHS to a 
mixed SAM of OT and MUA 
Quasi-reversible peaksforFeIII/FeII seen in anaerobic 
CV 
Yang et al.,2009 
 Electrochemically-driven catalysis with the 2C9 
substrate warfarin 
CYP3A4 fusion protein Gold Amine coupling via EDC/NHS to a 
mixed SAM of 6HT and 7MHA 
Microfluidic cell made of the 3A4 electrode 
amperometrically detected the 3A4 substrates 
quinidine, nifedipine, alosetron, and ondansetron 
Fantuzzi et al.,2010 
CYP2C9n1, 2C9n2, and 
2C9n3 CYP2D6n1, 
2D6n2, and 2D6n17 
Gold Amine coupling via EDC/NHS to a 
mixed SAM of 6HT and 
7MHA(2C9)Maleimide/thiol 
coupling to maleimide-terminated 
SAM (2D6) 
Micro-machined eight-electrode array used to 
amperometrically measure the KM and kcat values for 
the 2C9 substrate warfarin and the 2D6 substrate 
bufuralol 
Panicco et al.,2011 
CYPc17 Gold His-tag attachment via modified Ni-
NTA on na MPASAM in the 
presence of DDAB 
Redox peaks for FeIII/FeII seen in anaerobic CV Johnson and Martin, 2005 
Enhanced electroactivity when using His-tag 
attachment vs.amine-coupling 
CYP2E1 Gold Maleimide/thiol coupling to 
maleimide-terminated SAM 
Redox peaks for FeIII/FeII seen in anaerobic CV Faster 
(ks=10 s-1 ) electron transfer with maleimide/thiol 
coupling compared to adsorption to thin films 
Fantuzzi et al.,2004 
CYP2E1 Single-Cysteine 
Mutants 
Gold DTME SAM Electrochemically-driven catalysis with the 2E1 
substrate p-nitrophenol 
Mak et al.,2010 
CYP3A4 fusion protein Gold Maleimide/thiol coupling to 
maleimide-terminated SAM 
Electrochemically-driven catalysis with the 3A4 
substrate erythromycin 
Dodhia et al.,2008 
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Future Directions/Nanostructured Electrodes  
CYP11A1 Rhodium-graphite MWCNTs on screen-printed 
electrodes 
Enhanced amperometric detection (improved 
linearity) of cholesterol within clusion of MWCNTs 
Carrara et al.,2008 
CYP2B4, 2C9,3A4 Graphite or Gold MWCNTs on screen-printed 
electrodes 
Amperometric detection of benzphetamine (2B4), 
naproxen (2C9), and cyclophosphamide 
Enhanced limits of detection with inclusion of 
MWCNTs 
Cararra, et al.,2011 
CYP3A4 Sputtered Gold Adsorption to thin film of napthalene 
thiolate SAM 
Enhanced electroactivity on sputtered gold electrodes 
(ks=340 s-1) 
Mie et al.,2010 
CYP3A4 microsomes Microfabricated Gold 
Nanodomes 
Adsorption to thin film of napthalene 
thiolate SAM 
Enhanced electroactivity on nanostructured gold 
electrodes 
Ikegami et al.,2011 
CYP3A4 
 
Gold Amine coupling to ZnSe quantum 
dots covalently coupled to na 
MPASAM 
Amperometric detection of the 3A4 substrate 17β-
estradiol 
Ndangili et al.,2011 
Anodic shift in the redox potential with inclusion of 
quantum dots 
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1.4 Heme proteins
Both enzymes addressed in this thesis fall into the heme proteins category; Cytochrome
P450 (CYP) and Cytochrome c Nitrite Reductase (ccNiR).
Heme is perhaps the most ubiquitous cofactor found in nature and the most function-
ally diverse. Proteins containing a heme group constitute a heterogeneous family whose
functional impact in living organisms is exceedingly high, due to their involvement in a
large range of biological processes. By taking part in several metabolic processes within
living creatures, heme proteins play a key role in the maintenance of life on earth 181 .
Hemoproteins are involved in cell respiration (cytochromes), oxygen-binding and trans-
port (hemoglobin and myoglobin), oxidative biotransformations (cytochrome P450 and
peroxidases), and most recently discovered, as sensors in 2-component regulatory sys-
tems (guanylate cyclase, FixL, and CooA).
The ability of hemoproteins to carry out extremely diverse reactions arises largely
from the protein environment in which the heme molecule resides and specifically the
nature of the heme-ligands. Other factors that contribute to the reactivity of the heme
are intrinsic to the heme itself, including the substituents on the heme periphery and, in
some cases, the covalent attachment of the heme to the protein182.
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2
Experimental
2.1 Part A- Cytochrome P450 1A2
The cytochrome P450 1A2 (protein 10 mg/mL; CYP1A2 122 pmol/mg) was provided
by the Centro de Investigação em Genética Molecular Humana from IHMT. The protein
was purified as previously described in Palma et al.183, and stored in TGE buffer (75 mM
Tris.HCl, 10 % (v/v) Glycerol and 25 mM EDTA, pH 7,5) at -80 ◦C.
Caffeine was purchased from Sigma-Aldrich, the solutions were prepared in deion-
ized water (18MΩ/cm) from Millipore MilliQ or Purelab Option (Elga) water purification
systems.
2.1.1 Electrochemical measurements
A conventional three-electrode electrochemical cell was used, with an Ag/AgCl reference
electrode, a Pt counter electrode and a PGE (φ=3mm) modified with the enzyme/sol-gel
film, as working electrode. The electrochemical cell, containing 10mL of 0.5M PBS buffer,
pH 7 as supporting electrolyte, was thoroughly purged with argon before and an ar-
gon atmosphere was maintained inside the cell during the experiments. Measurements
were performed with a potentiostat Autolab PSTAT 12 (Eco-Chemie) monitored by the
control and data acquisition software NOVA 1.6. In cyclic voltammetry experiments, a
50mV/s scan rate was used unless otherwise stated. All potentials were quoted against
the Ag/AgCl reference electrode.
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2.1.2 Mediated electrochemistry of cytochrome P450
Before modification the PG working electrodes (self-made with 3 mm diameter disks
in glass tubes) were polished with alumina slurry (0.3 µm) from Buehler, thoroughly
washed with water and ethanol and ultra-sonicated in deionized water for 5 min. Finally,
the electrodes were washed with water and dried with compressed air.
The mediators used, 1,1’-dimethyl-4,4’-bipyridinium dichloride (methyl viologen, MV)
and 3,7-bis(Dimethylamino)-phenothiazin-5-ium chloride (methylene blue MB) were pur-
chased from Sigma. All chemicals were of analytical grade.
Table 2.1: Mediators structure and formal reduction potential.
Mediator structure E°' (mV)vs NHE 
Methylene 
Blue184 
 
-426 
Methyl 
Viologen130 
 
-440 
 
2.1.2.1 Mediator in solution
The electrode was prepared by depositing 7.5 µL of CYP1A2 on the PGE and drying at
room temperature for ca. 45 min. The assays were performed in the presence of 100 mM
of mediator (either MB or MV) in the electrochemical cell.
2.1.2.2 Electropolymerized mediator
Electropolymerization of methylene blue was performed by cyclic voltammetry (11 scans);
the CVs were traced at a scan rate of 100 mV/s in the potential window -0.6 to 1.2 V vs
Ag/AgCl , mediator concentration in solution was 100 mM.
After the mediator polymerization, a 7.5 µL drop of CYP1A2 was applied to the PGE
and left to dry at room temperature for ca. 45 min.
2.1.3 Direct electrochemistry
2.1.3.1 Direct adsorption
The PG working electrodes were cleaned as described above, subsequently a 7.5 µL drop
of CYP1A2 was applied on the electrode surface and left to dry at room temperature for
ca. 45 min.
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2.1.3.2 Surfactant films
The surfactant films were usually prepared from aqueous solutions which were cast onto
the electrode surfaces. After solvent evaporation, a water-insoluble multi-bilayered film
structure was formed (selfassembled). The structures of the surfactants used in the work
described in this section are shown in Figure 2.1.
Figure 2.1: Surfactant structures. Cationic head group: A) CTAB, B) DDAB; C) DDM
(n-dodecyl-b-D-maltoside).
The protein (CYP1A2) was confined within different surfactant films (Dodecyldimethy-
lammonium bromide (DDAB) and Cetyl Trimethyl Ammonium Bromide (CTAB) pur-
chased from Sigma-Aldrich and n-Dodecyl β-D-maltoside (DDM) from CalBiochem R©),
on the surface of basal-plane graphite electrodes (PGE) which were analyzed by cyclic
voltammetry. All chemicals were of analytical grade.
CYP1A2–surfactant solutions were prepared by mixing 1.0 mg/mL of enzyme with 2
times the CMC of each surfactant (see Table 2.2). These mixtures were then incubated at
room temperature (22 ± 2 ◦C) for 30 minutes. A 7.5 µL drop of mixture was then applied
to the PGE. The electrodes were dried at room temperature for ca. 45 min.
Table 2.2: Surfactant critical micelar concentrations.
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2.1.3.3 Sol-gel matrices
Sodium Silicate (Figure 2.2A) (Sigma-Aldrich), Tetraethoxysilane (TEOS, 98%, Alfa Ae-
sar) and Tetramethyl orthosilicate (TMOS 98%, Sigma-Aldrich) were used as the silica
precursor. Poly(ethylene glycol) (PEG, MW 400 and 6000)(Figure 2.2B) were purchased
from Prolabo.
A B
Figure 2.2: A) structure of sodium silicate; B) structure of poly(ethylene glycol).
Phosphate buffer solutions (PBS) were prepared with Na2HPO4•2H2O (99.5%, Merck)
and KH2PO4 (99.9%, Prolabo). Tris–HCl buffers were prepared using Tris(hydroxymethyl)aminomethane
(Sigma, 99.8%) and HCl (36%, Prolabo). All solutions were prepared with high purity
water (18MΩ/cm) from a Purelab Option water purification system (Elga).
The PG working electrodes were cleaned as described above. For the sol-gel modified
electrodes the surfaces were first treated by abrasion with sandpaper followed by the
regular procedure. The optimized hybrid sol-gel was prepared by mixing Sodium Silicate
55 mM and PEG400 6% at pH 7. Protein films were applied onto the electrode surface by
placing 10 µL of a solution containing equal parts of CYP1A2 and sol-gel. The electrodes
were left to air dry for 1h.
Table 2.3: Compositions of sol-gel based matrices using TMOS and CTAB.
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Table 2.4: Compositions of sol-gel based matrices using Sodium silicate and CTAB.
Table 2.5: Compositions of sol-gel based matrices using Sodium silicate and PEG400.
2.2 Part B- Cytochrome c Nitrite Reductase
The protein Cytochrome c Nitrite reductase from Desulfovibrio desulfuricans ATCC 27774
was purified at Requimte, FCT-UNL, according to the procedure described by Almeida
et al.149 and stored in 0.1 M phosphate buffer pH7.6, at -20◦C. The specific activity was
300 U/mg and the protein content 1.0 mg/mL.
2.2.1 Electrochemical measurements
conventional three electrode electrochemical cell was used, with an Ag/AgCl reference
electrode (Radiometer), a Pt counter electrode (Radiometer) and a PG electrode (φ= 3mm)
modified with the sol- gel/ccNiR film, as working electrode. The electrochemical cell,
containing 10 mL of PBS pH 7.0 as supporting electrolyte, was thoroughly purged with
argon before and an argon atmosphere was maintained inside the cell during the ex-
periments. Measurements were carried out with a potentiostat Autolab PSTAT 12 (Eco-
Chemie) monitored by the control and data acquisition software NOVA 1.6 (EcoChemie).
Cyclic voltammetry experiments were performed with a 50 mV/s scan rate in a potential
window of -0.1 to -0.8 V.
2.2.2 Response to nitrite
To evaluate the biosensors response to nitrite, the electrochemical cell was successively
spiked with standard solutions of sodium nitrite (0.01, 0.1 and 1 M). After each addi-
tion, the cell was again purged with argon for ca. 30 s and the CV was recorded. Nitrite
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catalytic currents were determined at the inversion potential (-0.8 V) unless stated other-
wise. All potentials were quoted against the Ag/AgCl reference electrode (-197 mV vs
NHE).
2.2.3 Hybrid sol-gel matrix
The sol-gel precursor Sodium Silicate was purchased from Sigma-Aldrich and the Poly(ethylene
glycol) (PEG, MW 400 and 6000) was acquired from Prolabo. Solutions were prepared
with deionized water (18 MΩcm) from a Millipore MilliQ water purification system. All
chemicals were analytical grade and were used without further purification.
The PGE working electrodes were cleaned as described in section 2.1.2). Protein films
were prepared by depositing a 10 µL drop of the preparation, containing the enzyme
solution (1.0 mg/mL) and the sol-gel (sodium silicate and PEG, either or kDa, were pre-
pared according to the formulation described in Table 2.5 with a ratio of 44/5, on the
electrode surface. After 60 minutes, the electrode was washed with buffer and placed in
the electrochemical cell.
2.2.4 Macroporous Carbon Nanotubes
ingle-walled carbon nanotubes functionalized with carboxylic groups (CNT, >90%, 4–
5nm 0.5-1.5 lm) were obtained from Sigma. Polystyrene beads (PS, φ ≈ 500 nm, 50mg/mL)
were prepared by emulsion polymerization in water solution following a protocol from
the literature M. Nagai et. al.185.
Glassy carbon plates used as working electrodes (GC, Sigradur R©, HTW Hochtemperatur-
Werkstoffe, Germany) were polished before and after modification by wet emery paper
4000 with Al2O3 powder (0.05 µm, Buehler).
Electrophoretic deposition of carbon nanotubes and polystyrene-beads was performed
using a cell consisting of stainless steel plate as cathode and glassy carbon plate as anode.
The two electrodes were placed parallel to each other and separated by 6 mm Figure 2.3.
The area of contact of each electrode with the dispersion was 1 cm2. The adequate voltage
was applied using a DC power supply.
Prior to enzyme coating, the GC plates working electrodes previously functionalized
with carbon nanotubes (as described in section 2.1.2) were rinsed with deionized water.
A drop of enzyme (7 µL) was then applied onto the modified electrodes which were left
drying for 40 min under an argon flux.
The carbon nanotubes dispersion (0.1 mg/mL) was obtained by sonication in an ul-
trasonic bath for 12 hours. The PS-beads were added under gentle stirring to the carbon
nanotubes dispersion prior to the deposition in order to achieve a final concentration of
0.025mg/mL . The two parallel electrodes were introduced in a 4mL aliquot of the CNT
or CNT-PS dispersion and a constant voltage of 60 V was applied for the required time.
The electrode dipping was kept constant in order to ensure the same area of contact with
44
2. EXPERIMENTAL 2.2. Part B- Cytochrome c Nitrite Reductase
the dispersion and therefore improve the reproducibility of the deposition. After depo-
sition, the glassy carbon plate was carefully removed from the remaining dispersion and
dried horizontally at room temperature. The electrodes prepared in such way were there-
after after called GC-CNT or GC-CNT-PS. The template (PS-beads) removal was carried
out in an oven at 450 ◦Cfor 1 hour with 15 ◦C/min ramp resulting in electrodes called
GC-CNT-(macroporous).
Figure 2.3: Scheme of the experimental device used for the electrophoretic deposition of
carbon nanotubes201.
A three electrode electrochemical cell was used Figure 2.4, with an Ag/AgCl reference
electrode (Radiometer), a Pt counter electrode (Radiometer) and a modified glassy carbon
plate as working electrode. The electrochemical cell containing 0.1 M KCl in 0.05 M Tris-
HCl buffer pH 7.6 as supporting electrolyte, was thoroughly purged with argon before
and during the experiments. Measurements were carried out with a potentiostat Autolab
PSTAT 12 (EcoChemie) monitored by the control and data acquisition software NOVA 1.6
(EcoChemie). Cyclic voltammetry experiments were performed with a 50 mV/s scan rate
in the potential window -0.1 to -0.8 V.
To evaluate the biosensors response to nitrite, the electrochemical cell was succes-
sively spiked with standard solutions of sodium nitrite (0.01, 0.1 and 1 M). After each
addition, the cell was again purged with argon for ca. 30 s and the CV (cyclic voltammo-
gram) was recorded. Nitrite catalytic currents were determined at the inversion potential
(-0.8 V) unless stated otherwise. All potentials were quoted against the Ag/AgCl refer-
ence electrode (-197 mV vs NHE).
The electrochemical experiments were performed according to section 2.2.1) except
for a few changes: namely, the electrochemical cell (Figure 2.3); the working electrode,
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and a modified glassy carbon plate as working electrode.
Work electrode
GC Plate connected to 
aluminum foil
Reference 
electrode  Ag/AgCl
Counter electrode  
Platinum
Figure 2.4: Electrochemical cell.
2.2.5 Oxygen scavenger system
Glucose oxidase (Type II from Aspergillus niger 17.3 U.mg-1) and catalase (from bovine
liver, 2-5kU mg−1) were purchased as lyophilized powders from Sigma and used as re-
ceived. All other chemicals were of reagent grade. Deionized water (18 MΩcm) was used
in all experiments.
Prior to modification the PG electrodes were cleaned as previously described. Protein
films were prepared by depositing a 10 µL drop of the preparation, containing the en-
zyme solution(s) and the sol-gel, on the electrode surface. After 60 minutes of air drying,
the electrode was washed with buffer and placed in the electrochemical cell.
The enzymatic scavenger system constituted by glucose oxidase and catalase was
tested in different ways: 1) with sol-gel immobilized ccNiR (4.5 U) and GOx (9.3 U/mL)
and catalase (650 U/mL) in solution in the electrochemical cell; 2) sol-gel immobilized
ccNiR (4.5 U) and catalase (41.7 U) with GOx (9.3 U/mL) in solution and.
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Results and discussion
3.1 Cytochrome P450 1A2
Aiming at the development of an electrochemical CYP1A2 based biosensor, P450 enzyme
was used either in presence or absence of its natural redox partner (CYPOR complex).
The different strategies were investigated using cyclic voltammetry. The experimental
design has taken into account the need to establish an effective electronic communication
between the enzyme and the electrode and, at the same time, preserve the biological
activity. It is important to note that to probe the catalytic activity of CYP1A2, caffeine
was selected from a plethora of substrates due to its low cost, availability and moderate
water solubility. In general, the co-substrate - molecular oxygen - was provided to the
medium dissolved in the caffeine aqueous stock solutions or, alternatively, in deionized
water. Unless stated otherwise the experiments were carried out in a purged electrolyte
solution in order to remove oxygen which exhibits a broad waved that might mask the
non-catalytic signals of P450.
3.1.1 Cytochrome P4501A2 in the absence of CPR
The following section describes several strategies tested with the purpose of establishing
the electronic communication between the cytochrome and the electrode. At an initial
stage, a mediated approach was used that later proved itself inadequate to our goals.
This approach was discarded in favor of direct electrochemistry.
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3.1.1.1 Mediated electrochemistry
Selection of a suitable mediator Three mediators were selected and tested as elec-
tron shuttles, namely methyl viologen, methylene blue and methylene green (either in
monomeric or polymeric forms). These substances have sufficient negative potentials
compared to the redox potentials of the active sites of P450 (-0.4V ± 0.1V) and might
reduce the oxidized form (PFeIII) of the enzyme. In a first approach CVs were recorded
with the CYP immobilized on the PG electrode in the presence of dissolved mediators.
Following the addition of a caffeine stock solution, catalytic reduction currents could
clearly be observed (Ic increases while Ia decreases); to illustrate this behavior Figure 3.2
and Figure 3.3 show the CV of methyl viologen and methylene blue in the presence of
an electrode with membrane entrapped-CYP. This means that the reduced forms of each
mediator were able to deliver electrons to a CYP which in turn, passes the electrons to
the substrate (MV Figure 3.2 and MB Figure 3.3). However, control experiments done
in the absence of caffeine (additions of non-purged water aliquots) produced a similar
behavior. It became clear that the catalytic response was due an increase in the oxygen
concentration (water dissolved) and not the caffeine’s (Figure 3.1). On the other hand,
control experiments performed in the absence of protein did not show significant current
variations. Apparently, despite CYP being able to reduce molecular oxygen, the organic
substrate caffeine is not participating in the catalytic reaction.
Figure 3.1: Schematic representations of the working principles of a CYP Bioelectrode
with mediated transduction.
Because at this stage the focus was on the catalytic response of CYP to caffeine only,
this approach was abandoned.
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Figure 3.2: A) Cyclic voltammograms of methyl viologen in the presence of CYP mem-
brane entraped on a PG electrode, buffer solution 0.1 M MV, 0.1 M KCl and tris-HCl
buffer 50 mM pH 7.6. in the presence of varying caffeine concentrations (0-42mM).Scan
rate: 50mV s−1.B Icat variation with nitrite concentration.
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Figure 3.3: 3 A) Cyclic voltammograms of methylene blue in the presence of CYP on a
PG electrode, buffer solution 0.1 M MV, 0.1 M KCl and tris-HCl buffer 50 mM pH 7.6. in
the presence of varying caffeine concentrations (0–42mM).Scan rate: 50mV s−1.B . B) Icat
variation with nitrite concentration.
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3.1.1.2 Direct electrochemistry of cytochrome P450
Direct electrochemistry of cytochrome P450 in surfactant films Because the electro-
chemically mediated experiments did not give the expected full catalytic response, it was
decided to use a DET approach. In fact, direct electrochemical reduction has the potential
to provide P450s with reducing equivalents, thereby eliminating the native ET machinery.
The first attempt at direct electrochemistry was carried out in the absence of surfac-
tants or other stabilizing components. The successive voltammograms depicted in Figure
3.4A show the change in the non-catalytic signals of cytochrome P450 1A2 with time.
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Figure 3.4: Consecutive cyclic voltammograms of CYP1A2–surfactant films casted on PG
electrodes in 0.1 M KCl and tris-HCl 50 mM pH 7.6; scan rate 50 mV/s. A) Control
electrode with CYP1A2 only, B) DDM C) DDAB, D) CTAB.
Although a small and broad redox wave could be observed in the range -0.3;-0.5 V the
signal promptly disappeared; this signal is similar to the ones observed in electrochemi-
cal experiments using other cytochromes P45075,163,186,187, leading to the conclusion that
this non-catalytic signal is correlated with the reduction and reoxidation of P450FeIII/FeII.
This signal was not systematically observed and, when observed, was of very small in-
tensity, probably due to of the small amount of protein that was able to reach the re-
quired orientation to keep the conformation for direct electron transfer reaction and/or
to a small ET rate.
In order to improve the protein stabilization and subsequent direct electron transfer
it was decided upon the use of surfactants. This CYP is a membrane-bound protein for
which a more hydrophobic environment could be beneficial. Surfactant assemblies on
carbon electrodes have been shown to facilitate direct ET with various P450s74,188,189. The
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protein was therefore incorporated into surfactant layers deposited on the electrode.
All the surfactants tested were used in a concentration corresponding to 2xCMC to
ensure that micelles could be formed on the electrode and, in this way, equivalently com-
pare the effects of the surfactants on the enzyme’s electrochemical response.
Cyclic voltammograms of CYP1A2–surfactant films casted on PG electrodes are shown
in Figure 3.4. The peak potential was never shifted, no matter the surfactant type. The
voltammograms depicted in Figure 3.4 show a consistency in the electrochemical behav-
ior of the protein in different surfactant films. It is easier to observe in Figure 3.4 B and D,
that the peak potential is in the -0.350 to -0.400V range, and that it shifts slightly to more
negative potentials over time.
The reported studies on heme proteins, like hemoglobin and myoglobin, considered
that the DDAB surfactant films could favor a specific orientation of the proteins embed-
ded in them, due to interaction with the cationic head group or the hydrocarbon chains
of DDAB63,68. However, in this study DDAB did not provide the best results. On the
contrary, DDM and CTAB enabled a better electrochemical response. CTAB in particu-
lar, a cationic surfactant such as DDAB, greatly enhanced the DET of CYP with the PG
electrode, therefore, it was selected for further studies.
The effect of the scan rate is shown in Figure 3.5. The cathodic peak currents in-
creased linearly with the scan rate up to 1 V/s which is consistent with a diffusionless
electrochemistry (Figure 3.5); only CVs with a scan rate up to 0.5 V are shown). The ab-
sence of the symmetrical counterpart of the peak located at -375 mV indicates that the
electrode reaction is nonreversible.
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Figure 3.5: Variation of the cathodic peak currents on the potential with the scan rate
(5-500 mV/s) (y=-2.48*10-8-4.48*10−10x; r2=0.992)
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The catalytic activity of the CYP1A2-CTAB films towards caffeine was investigated;
substrate solutions were deoxygenated before addition to the electrochemical cell. Once
again, no relevant changes could be detected in the voltammograms, i.e., there was no
catalytic activity (results not shown).
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Stabilization of membrane-bound P450 protein for bioelectrochemistry
Sensor optimization The optimum membrane composition was selected from a
group of sol-gel formulations prepared with different precursors, water: monomer molar
ratios and enzyme quantities. The bioelectrodes were characterized by cyclic voltamme-
try.
The first efforts were based on formulations containing CTAB, due to the results ob-
tained in the previous section. The formulations based on the sol-gel precursors TEOS
and TMOS had a tendency to precipitate, regardless the solvent/precursors/surfactant
ratios tested (Table 2.3). The sol-gel films had a thin and glassy appearance, but a high
tendency to fracture during the drying process, occasionally loosing small pieces of glass.
For these reasons these precursors were discarded and it was decided to test a different
type of precursor, sodium silicate.
The sol-gel matrices prepared by the combination of sodium silicate and CTAB (Ta-
ble 2.4) provided fairly more positive results (20 mM sodium silicate, 5 mM CTAB). Still,
the film was thin and brittle. Although it was possible to obtain an electrochemical re-
sponse, it was lost once the film cracked. Besides PEG being known to improve sol-gel
consistency, it has also been reported as a stabilizing agent for P450 in electrochemical ex-
periments at high temperature190. Thus, it was tested here to immobilize CYP1A2 (Figure
3.6C). However, no signal was observed in these conditions. The immobilization in sili-
cate was also considered (Figure 3.6B), leading to a slight improvement in the measured
electrochemical signal.
Next, sol-gel/enzyme films were prepared with the combination sodium silicate and
polyetilene glycol (Table 2.5). With the optimal formulation: 55 mM sodium silicate and
6.25% PEG400 it was possible to obtain a hybrid film stable enough to continue our work.
These results lead to the assumption that the use of sodium silicate prevents the introduc-
tion of alcohol in the starting sol, while PEG improves the stabilization of the membrane
protein. This hybrid sol-gel formulation has not been previously reported and its reaction
mechanism is not yet been established.
As previously stated, only the combination of PEG and silicate led to well defined
redox peak at -0.335 V versus Ag/AgCl. The redox signal decreased rapidly by a factor
of three during the first minutes of placing the electrode in electrolyte solution (Figure
3.7). Most likely, the weakly immobilized protein molecules are leaching out from the
film and only the stably encapsulated CYP remains attached in the hybrid sol-gel film for
long time experiments. This set of results clearly show that neither PEG nor silicate are
able to immobilize CYP1A2 in an electrochemically active form and only the synergetic
effect from their combination allows the redox activity of the membrane-bound protein.
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Figure 3.6: Cyclic voltammograms of CYP1A2 casted on PG electrodes, in 0.1 M KCl
and tris-HCl 50 mM pH 7.6 purged electrolyte; scan rate 50 mV/s, in the presence of A
only CYP; B CYP/Sodium Silicate; C CYP/Peg400; D CYP/Sol-gel(sodium silicate and
PEG400).
Characterization of the non-catalytic signals The bioelectrodes, prepared with the
hybrid sol-gel formulation described in the previous section were, characterized by cyclic
voltammetry. A non-catalytic current-potential curve was always observed in purged
electrolyte without caffeine (Figure 3.7); the peak potential is coherent with the one ob-
tained in the presence of surfactants (previous section) as well as the potentials described
in the literature for the heme iron reduction191. However, according to the literature,
the CYP1A2 electrochemical signal in the absence of oxygen should depict the reversible
electrochemical conversion of PFeIII/PFeII indicating that perhaps the vestigial oxygen
concentration present in the sol-gel film/electrolyte is causing the anodic signal to disap-
pear. This phenomena will be further discussed in the next section.
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Figure 3.7: Consecutive cyclic voltammograms of PG/CYP1A2–sol-gel film electrode in
0.1 M KCl and 50 mM tris-HCl buffer pH 7.6 purged with argon. scan rate 50 mV/s.
The electrochemistry of sol-gel encapsulated CYP1A2 was studied by changing sys-
tematically the potential scan rate from 5 to 1000 mV s-1 as reported in Figure 3.8. Only
one peak could be observed, and its current intensity increased linearly with scan rate’s
square root which is consistent with a diffusion controlled electrochemistry (Figure 3.8).
The enzyme is thought to be immobilized in a matrix that does not prevent diffusion
since no deviation from linearity is observed between peak current and square root of
the scan rate up to 1 V/s (Figure 3.8 only shows up to 0.50 V/s).
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Figure 3.8: A) Cyclic voltammograms of PG/CYP1A2–sol-gel film electrode in 0.1 M KCl
and 50 mM tris-HCl buffer pH 7.6 purged electrolyte at different scan rates; from inside to
outside: 0.005, 0.01, 0.02, 0.05, 0.1, 0.2, 0.25 V.s−1, respectively. B) Variation of the cathodic
peak currents on the potential scan rate (y=-0.03-0.017x; r2=0.98).
Response to oxygen and caffeine The chemistry of oxygen activation catalyzed by
the P-450s has always been a topic of great controversy. The heme iron of P450 is coorde-
nated by a cysteine as the fifth ligand. The sixth position is left vacant for oxygen binding
during catalysis - but may be occupied by a water molecule in the resting state. The in-
fluence of dissolved oxygen on the electrochemical response of CYP1A2 immobilized in
sol-gel (PEG400 and sodium silicate), observed in Figure 3.9 reveals that when the elec-
trode is exposed to a high percentage of oxygen the cathodic signal, however intense in
the first scan, quickly disappears. The electrochemical response measured for the first
cyclic voltammogram showed a well-defined peak with a current intensity higher than 8
µA and maximum peak potential at -0.355 V vs Ag/AgCl. Still, continuous cycling at 50
mV s-1 leads to a continuous signal degradation and a peak shift to lower potentials. Ac-
cording to Rusling191, after electrochemical reduction of P450-FeIII in aerobic solution,
reduced form PFeII is combined with dioxygen to form PFeII -O2 complexes and this
complex might be further reduced electrochemically, yielding hydrogen peroxide and re-
generating the PFeII heme192,193. The peroxide generated in this catalytic reduction of
oxygen reacts with cyt P450FeIII to form +•(P450-FeIV=O), which should be reduced at
the electrode to regenerate cyt P450-FeIII (Figure 3.10), the lectroactive species whose re-
duction is being monitored. Though, this regeneration does not appear to occur, which
leads to the possible conclusion that the cycle described in the scheme is blocked in one
of the steps. In such a case there are three hypotheses:
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i) The window of potential in which the reaction was analyzed is not negative enough
to reduce the +•(P450-FeIV =O), in other words, there is a lack of a driving force able
to reduce this form of P450 making it impossible to regenerate the PFeIII (step 6
blocked);
ii) The PFeIII heme degradation due to hydrogen peroxide accumulation (c.f. 3.2.3)
(step 5 blocked);
iii) The CYP’s conformational change necessary for P450-FeII -O2 conversion in hydro-
gen peroxide and P450-FeII does not occur (step 3 blocked).
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Figure 3.9: Consecutive cyclic voltammograms of PG/CYP1A2–sol-gel film electrode in
0.1 M KCl and 50 mM tris-HCl buffer pH 7.6 aerobic conditions. scan rate 50 mV/s.
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Figure 3.10: Pathways for Biocatalytic Activation of Cyt P450s by Peroxides, Oxygen
Reduction Formed Peroxide.by P450s on Electrodes.
The results obtained upon the addition of purged caffeine aliquots turned out to be
equivalent to the ones acquired when using redox mediators or DET with surfactants,
meaning no catalytic response could be observed (Figure 3.11). This signal represents
step 1 (Figure 3.10) in the presence of small amounts of oxygen (vestigial). If the condi-
tions were completely anaerobic the signal should be reversible. However, in the pres-
ence of oxygen the equilibrium is shifted in the direction of PFeIIO2 formation, turning
the reaction (step 1) irreversible.
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Figure 3.11: Cyclic voltammograms of CYP1A2–sol-gel film casted on PG electrode,
buffer solution, 0.1 M KCl and tris-HCl 50 mM pH 7.6 purged with argon. In the presence
of varying caffeine concentrations in the absence of oxygen. Scan rate: 50mV s−1.
Figure 3.12 reports the electrochemical response of CYP1A2 immobilized in the sol-
gel-PEG hybrid film to an increasing amount of non-deareated caffeine. The experiment
was initiated in an oxygen free solution (purged with Argon). Then, small volumes of a
non-purged caffeine solution were introduced in the cell, leading to the gradual increase
in the cathodic peak intensity and a decrease in the anodic currents. It important to
note that the data was plotted against the volume of caffeine added, in order to have a
comparison term with the experiments where water additions were made.
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Figure 3.12: Cyclic voltammograms of CYP1A2–sol-gel film casted on PG electrode,
buffer solution, 0.1 M KCl and tris-HCl 50 mM pH 7.6 purged with argon. In the presence
of varying non-purged caffeine volumes (stock solution 60 mM). Scan rate: 50mV/s.
Conversely, control experiments carried out adding equivalent volumes of deareated
water, provided the same results revealing that the responses observed was due to an
increase in oxygen catalysis and not to caffeine’s (Figure 3.13). The following experiment
was initiated in an oxygen free electrolyte solution. When small non-purged water vol-
umes were added to the solutions bathing CYP1A2/sol-gel/PG electrodes, the PFeIII
reduction peak increased greatly (Figure 3.13). This is the classic voltammetric signature
for electrochemical catalysis. Here, it the reflects reaction of PFeII with dioxygen (step 2
of Figure 3.10) followed by reduction of the PFeII -O2 complex to give H2O2 , regenerat-
ing PFeII to continue the reaction cycle (step 3 of Figure 3.10).
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Figure 3.13: Cyclic voltammograms of CYP1A2–sol-gel film casted on PG electrode,
buffer solution, 0.1 M KCl and tris-HCl 50 mM pH 7.6 purged with argon. Consecutive
additions of non-purged water. Scan rate: 20mV s−1.
3.1.1.3 Catalase
As previously mentioned, hydrogen peroxide formation might be one of the reasons why,
in the presence of high concentrations of oxygen, the catalytic peak, corresponding step
1 (Figure 3.10), disappears after a few scans (Figure 3.9). In an attempt to avoid heme
degradation from hydrogen peroxide exposure194 several experiments were carried out
in the presence of catalase. This enzyme is a commonly found in nearly all living organ-
isms exposed to oxygen. A number of recent studies indicate that catalase is the primary
enzyme responsible for protecting the cells from hydrogen peroxide by catalyzing the
fast decomposition of hydrogen peroxide to water and oxygen Equation 5.
H2O2 → H2O2 +O2 (3.1)
Table 3.1 shows the experiments performed to diminishing the peroxide’s impact in
the P450’s electrochemistry. It can be seen that the catalase addition to the cell does
not prevent the decrease in the signal’s intensity, regardless some assumptions can be
made concerning the profile of the cyclic voltammograms. The twisted reverse trace
phenomenon tends to increase in the presence of catalase at lower scan rates, according
to what Limoges et al. reported194 this is characteristic of a chemical inactivation–redox
reactivation mechanism. Additionally, when looking at the negative sweep and consider-
ing the results obtained by Butt et al.195 when studying Nitrite reductase in the presence
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of inhibitors, is possible to infer that the combination of the magnetic stirring and the
lower scan rate promotes hydrogen peroxide removal of the electrode surface.
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Table 3-1 Compilation of several electrochemical experiments with sol -gel/CYP1A2 in anaerobic conditions.  
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3.1.2 CYPOR complex
In order to better understand the results obtained with CYP1A2 namely, the lack of cat-
alytic activity towards caffeine, similar experiments were performed with the CYPOR
complex. Considering that in vivo, as previously discussed in section 1.3.1), the CPR
transfers the electrons form NADPH to the cytochrome, it would be expected that, in
the presence of the cytochrome P450 reductase there could be catalytic activity towards
caffeine. For the immobilization of the CYPOR complex the same sol-gel was used as de-
scribed in section 3.1.1.2)b)). The CVs revealed a cathodic peak at -0.2 V and a small an-
odic wave at -0.33 V. As observed in Figure 3.14 the cathodic peak currents vary linearly
with the scan rate in a 5-500 mV/s range. This behavior indicates that the electrochemical
reduction of CYPOR is not controlled by diffusion inside the sol-gel film. Although the
cyclic voltammograms depicted in Figure 3.14 do not fulfil the reversibility criteria, we
are now able to observe an anodic peak, unlike what happened in the absence of the CPR.
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Figure 3.14: A) Cyclic voltammograms of PG/CYPOR–sol-gel film electrode in 0.1 M KCl
and 50 mM tris-HCl buffer pH 7.6 in a purged electrolyte at different scan rates; from
inside to outside: 0.005, 0.01, 0.02, 0.05, 0.1, 0.2, 0.25 V.s-1, respectively. B) Variation of the
cathodic peak currents on the potential scan rate (y=1.85x10-10−8.39x10−10x; r2=0.997).
In aerobic conditions, the CYP bioelectrode’s CVs reveal a sharp catalytic peak. Heme–
iron containing enzymes such as P450 have, not only, the ability to incorporate an oxy-
gen atom from O2 into organic substrates, but also to utilize H2O2 and other peroxides
in the one-electron oxidation of the different cosubstrates (peroxidase activity)196. This
fact should account for the heme protection from degradation while exposed to hydro-
gen peroxide, but as it was discussed in the previous sections, this does not occur (Figure
3.15B). Nonetheless, in the experiments containing CPR (Figure 3.15A) it is possible to
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observe that the catalytic activity does not disappear. In fact, although a decrease of cur-
rent intensity occurs in the first 10 cycles, at that point the signal stabilizes still displaying
a “strong” catalytic activity, leading to the supposition that the CPR is somehow related
to the peroxidase activity of the cytochrome P450.
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Figure 3.15: Cyclic voltammograms of films casted on PG electrode in aerobic condi-
tions, buffer solution, 0.1 M KCl and tris-HCl 50 mM pH 7.6. Scan rate: 50mV s−1.of A)
CYPOR–sol-gel B) CYP1A2–sol-gel film. a) 1st scan b) 20th scan.
The difference observed helps sustain the hypothesis postulated in the previous sec-
tion, stating that a change in the CYP’s conformation is required in order to perform the
P450-FeII -O2 conversion in hydrogen peroxide and P450-FeII (step 3, Figure 3.7); there-
fore CPR is an essential element for the structural rearrangement. Upon the addition
of small volumes of non-purged water to electrochemical cell an increase in the CYP’s
catalytic response is observed (Figure 3.16).
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Figure 3.16: The effect of O2 binding on the electrochemistry of the CYPOR/sol-gel casted
on a PG electrode, purged buffer solution, 0.1 M KCl and tris-HCl 50 mM pH 7.6. Con-
secutive additions of non-purged water. Scan rate: 50mV s−1.
Interestingly, unlike what was observed in the previous experiments carried out, in
the absence of CPR, when caffeine was added to the electrochemical cell, already con-
taining a non-saturating oxygen concentration, a decrease in the catalytic current was
observed (Figure 3.17). A similar catalytic current decreasing phenomenon has been de-
scribed in the literature with glucose oxidase. Liu et al.197 for instance reported a de-
crease in the catalytic response upon glucose addition. In the work reported, GOD(FADH2),
electrocatalyzes the reduction of dissolved oxygen according to following equations.
GOD(FAD) + 2e− + 2H+ ↔ GOD(FADH2) (3.2)
GOD(FADH2) +O2 ↔ GOD(FAD) +H2O2 (3.3)
In the presence of glucose the electrocatalytic reaction is restrained due to the enzyme-
catalyzed reaction between the oxidized form of GOD, GOD(FAD), and glucose, which
then results in a decrease of electrocatalytic response (Equation 3.4).
Glucose+GOD(FAD)→ gluconolactone+GOD(FADH2) (3.4)
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Figure 3.17: Cyclic voltammograms of CYPOR/sol-gel films casted on PG electrode in
anaerobic conditions, buffer solution, 0.1 M KCl and tris-HCl 50 mM pH 7.6 purged with
argon.scan rate, 50 mV/s.(black-line) without substrates (red-line) oxygen addition (blue
and green lines) caffeine additions increased concentration.
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3.2 Cytochrome c nitrite reductase
n recent years, several ccNiR (D. desulfuricans ATCC 27774) based electrochemical biosen-
sors have been proposed125. Herein, this well-established biosensor system was used as a
model to evaluate new immobilization platforms and operation methods. Unless stated
otherwise, the experiments were carried out in a purged electrolyte solution in order to
remove oxygen, which exhibits a broad waved that might mask the (non-) catalytic sig-
nals of ccNiR. In this section, several approaches will be presented, whose purposes were
to improve the electronic communication and diminish the effect of interferences in the
ccNiR based sensor. The first strategy focused on the optimization of the use of the sol
gel formulation developed in section 3.1.1.2) using ccNiR as a model enzyme. In a second
approach, the electrophoretic deposition of macroporous assemblies of single-walled car-
bon nanotubes (SWCNTs) was used with the goal of improving the sensitivity of ccNiR
based nitrite biosensors. Lastly, an oxygen scavenger system was explored with the aim
of avoiding the mandatory oxygen removal when working with reductase enzymes.
3.2.1 Hybrid sol-gel matrix
Like CYP1A2, ccNiR is a heme containing protein associated to the periplasmic mem-
brane; for this reason, the matrix previously used for CYP immobilization was tested.
This time, the sol-gel film was optimized by varying the polymer’s size.
3.2.1.1 Non catalytic signals
As shown in Figure 3.18, the CVs of the PEG400 based films have higher cathodic peak
currents, which can indicate that this matrix is more suitable for the detection of the
electrochemical signals of ccNiR. The non-turnover currents should reflect the amount of
immobilized enzyme molecules and their ability to interact with the electrode. The CVs
of the PEG400 based films produce a higher cathodic peak currents, which can indicate
that this matrix is more suitable for the direct ET with ccNiR. Though, the results were
somewhat surprising because the higher polymer size of the PEG6000, is was expected to
provide larger pore sized films which constitute a more appropriate environment for the
incorporation of the large molecular weight aggregates of ccNiR (as purified this enzyme
is normally found is aggregates of over 890 kDa)149. In effect, other sol-gel formulations
tested in the past124, using diferent monomer precursors indicated that those providing
the largest porosity delivered the best results. Such broad envelope comprises all hemes
belonging to both NrfA and NrfH subunits (14 hemes, per NrfHA trimer) with reduction
potentials ranging +150mV to 400mV vs NHE, as previously stipulated by protein film
voltammetry, using an enzyme layer directly adsorbed on pyrolitic graphite electrode
surface. Since the potential of the cathodic peak was more negative when ccNiR was
entrapped in the PEG400 based formulations, perhaps in this case, the electrochemical
reaction beneath is related with the reduction of the more negative hemes. This might be
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a consequence of different molecular reduction within this sol- gel matrix. Future surface
characterization of these two enzyme films should indicate if the protein is effectively
encapsulated in both of them. If ccNiR is embedded only in the PEG6000 sol-gel, then the
direct electrode contact on the PG surface may be somewhat impaired, and in contrast,
with the PEG400 sol-gel but heterogeneously deposited on the electrode surface.
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Figure 3.18: Cyclic voltammograms of ccNiR immobilized on sol -gel films, buffer solu-
tion, 0.1 M KCl and tris-HCl 50 mM pH 7.6 purged with argon.scan rate, 20 mV/s. A)
ccNiR entrapped in a sodium silicate and PEG400 film B) ccNiR entrapped in a sodium
silicate and PEG6000 film.
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3.2.1.2 Response to nitrite
To assess the dependence of the catalytic current on the concentration of the substrate,
cyclic voltammograms of the PG/ccNiR-PEG modified electrodes were registered at var-
ious nitrite concentrations. The correspondent cyclic voltammograms for a PG/ccNiR-
PEG6000 electrode are presented in Figure 3.19; they show increased cathodic peak cur-
rents correlated with the substrate amount. This reflects the electroenzymatic reduction
of nitrite to ammonium and hence, a direct electrical connection of ccNiR to the electrode
surface.
-0.9 -0.8 -0.7 -0.6 -0.5 -0.4 -0.3 -0.2 -0.1 0.0
-3.00
-2.80
-2.60
-2.40
-2.20
-2.00
-1.80
-1.60
-1.40
-1.20
-1.00
-0.80
-0.60
-0.40
-0.20
0.00
0.20
C
u
rr
e
n
t 
(
A
)
E versus Ag/AgCl (V)
N
it
ri
te
0µM
500µM
Figure 3.19: Electrochemical response of PG/ccNiR–sol-gel film(PEG6000) electrode to
varying nitrite concentrations (0-500µM) in 0.1 M KCl and 50 mM tris-HCl buffer pH 7.6
purged with argon. Scan rate, 20 mV/s.
Figure 3.20 shows the relation between the catalytic currents and nitrite concentration
for ccNiR/PEG400 and ccNiR/PEG6000 electrodes. Apparently, the nitrite reducing ac-
tivity follows a typical Michaelis-Menten behavior, i.e. a steady increase of the catalytic
currents is observed, with a linear range extending up to 100 µM of nitrite and reaching
a plateau at higher concentrations.
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Figure 3.20: Variation of Icat with nitrite concentration of ccNiR immobilized on sol-gel
films A) ccNiR entrapped in a sodium silicate and PEG6000 film B) ccNiR entrapped in a
sodium silicate and PEG400 film.
The sensitivity of the bioelectrodes, as determined by the slope of the linear part of
the calibration curve (Figure 3.20) is 197 mA/M.cm2 and 12.7 mA/M.cm2 for the cc-
NiR/PEG400 and ccNiR/PEG6000 bioelectrodes, respectively, while the maximum cur-
rents at saturating nitrite concentrations (500µM) are -0.109 µA and -2.47 µA, respectively.
These results are somewhat contradictory when compared with the non-turnover signals
seen in section 3.2.1)3.2.1.1), considering that ccNiR/PEG6000 gave a poor non- catalytic
response and in the presence of nitrite, the catalytic response is more than ten-fold that
of ccNiR/PEG400 electrode. Nonetheless, this result was anticipated because, as men-
tioned previously, a higher pore size was expected to be more suitable not only for the
accommodation of the large ccNiR aggregates, as well as to guide protein molecules to-
wards the electrode surface with PEG6000 based sol- gel., but also for the mass transport
of the substrate. Another possibility for the improved behavior of PEG6000 lies on the
assumption previously made, that the cathodic peak’s potential is closer to that of the
catalytic site. Within the 3Dmatrix, the sensitivity of the PEG6000 electrode is slightly
lower than most of the values reported for the preceding nitrite biosensors constructed
with the same enzyme 39(cf. Table 1.5).
The lower detection limit at a signal to noise ratio of 3 was 2 µM and 0.19 µM for
ccNiR/PEG400 and ccNiR/PEG6000 bioelectrodes respectively; these values are similar
to the previously reported LODs of ccNiR based biosensors and meet the requirements
for nitrite monitoring in drinking waters according to European Union rules (maximum
admissible level <0.1 ppm, i.e., 2.2 µM). Nevertheless, one should consider further opti-
mization studies, using different amounts of enzyme and sol-gel concentrations.
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3.2.1.3 Stability
The sol-gel/ccNiR modified electrodes were stored at 4◦Cand tested for stability. Calibra-
tion curves were periodically traced and the maximum currents and sensitivity for nitrite
were evaluated. Figure 3.21 shows the gradual decrease in the ccNiR’s catalytic response
to nitrite over time (80 days) in a ccNiR/PEG6000 bioelectrode. The ccNiR/PEG400 elec-
trodes had a similar profile but maintained their catalytic activity for a shorter period (9
days).
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Figure 3.21: Variation of Icat with nitrite concentration of ccNiR immobilized on sol-gel
films A) ccNiR entrapped in a sodium silicate and PEG6000 film B) ccNiR entrapped in a
sodium silicate and PEG400 film.A) Variation of Icat with nitrite concentration of ccNiR
immobilized on PEG6000 sol-gel films over time. B) Time effects on the biosensor sensi-
tivity for nitrite determination. Sensitivity values were given by the slope of calibration
curves performed periodically throughout 80 days. Catalytic currents wer e measured at
- 0.8 V vs Ag/AgCl.
A steep decrease in maximum current and sensitivity occurs in the first day, with
both matrices. Nevertheless, it is clear that the PEG400 leads to a complete loss of ac-
tivity faster than the PEG6000 sensor (ccNiR/PEG400 loses activity after 9 days while
ccNiR/PEG6000 keeps 50% of its initial activity after 2 weeks). Most likely this is due to
denaturation or/and lixiviation of the enzyme in the sol-gel matrices. Though, it is worth
mentioning that the long period in which the ccNiR/PEG6000 configuration remains ac-
tive is quite promising, and a future optimized formulation possibly comprising enzyme
stabilizing agents could originate a more reliable and stable biosensor.
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3.2.2 Macroporous carbon nanotubes
The electrophoretic deposition allows the formation of macroporous CNTs layers from
suspensions of charged particles on the electrode surface. The carbon nanotubes are neg-
atively charged in a broad pH range198 due to the presence of carboxylic groups on
their surface. They move to the anode during the deposition and form a dense intercon-
nected network with a two-dimensional geometry and irregular mesopores caused by
voids between the randomly distributed carbon nanotubes199.The polystyrene beads are
also negatively charged due to the presence of sulfonate groups on their surface (potas-
sium persulfate was used as initiator of the polymerization in their synthesis200) and can
be electrophoretically deposited as well. Variation of the deposition time affects thick-
ness/amount of CNTs deposited.
The influence of the amount of deposited macroporous SWCNT on the catalytic re-
sponse of ccNiR was evaluated by CV on glassy carbon plates. The deposition time was
varied between 30s and 240s. Figure 3.22 depicts the effect of increasing nitrite concen-
trations on the ccNiR/CNT-PS electrode prepared with a 240s deposition time.
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Figure 3.22: Electrochemical response of PG/CYP1A2–sol-gel film electrode to varying
nitrite concentrations (0-300mM) in 0.1 M KCl and 50 mM tris-HCl buffer pH 7.6 purged
with argon. Scan rate, 20 mV/s.
Figure 3.23 shows that higher deposition times, and consequent higher nanotubes
amounts deposited on the electrode, results in an increased ccNiR response to nitrite.
Yet, the sensitivity, as determined by the slope in the linear part of the catalytic current
vs. substrate curve, did not improved with the amount of macroporous material (results
not shown) and only a higher maximum current at saturating substrate concentrations
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was observed.
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Figure 3.23: Catalytic current variation of the ccNir/CNT-PS layer as a function of nitrite
concentration. Macroporous SWCNTs deposition time. (black) 30s; (red) 135s; (green)
180s; (blue) 240s.
The deposition times were chosen based on the work developed at LCPM-CNRS
Nancy201 , which demonstrated that above 240s the film stability starts to decrease. In the
conditions tested in this work it was also possible to observe that there is hardly any dif-
ference between the 180s and 240s configurations. This behavior is in agreement with the
results presented by Etienne et al.201 very recently, because the film thickness is expected
to start stabilizing after 100s deposition time. Bearing in mind that there is an improved
response with the amount of nanotubes, the results presented above are considered pos-
itive. Still, these experiments are preliminary and further work must be accomplished to
better understand the system,for instance, the study of difference between the presence
and absence of the PS beads would be quite interesting.
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3.2.3 Oxygen scavenger system
The majority of electrochemical nitrite biosensors are used under anaerobic conditions,
usually by eliminating the electrolyte’s oxygen content by inert gas bubbling. Herein an
enzyme-catalyzed O2 removal system, based on the protocol developed by Plumeré et
al.202 will be studied, in order to use a nitrite reductase based biosensor under ambient
air electrochemical cells. The glucose-GOx-CAT system (Figure 3.24) was thus tested with
respect to its ability to remove oxygen and maintain anaerobic conditions in unstirred
electrochemical cells open to ambient air.
Figure 3.24: Scheme of the GOx-CAT scavenging system.
The oxygen scavenger system was tested with the sol-gel/ccNiR system described
in section 3.1.1.2)b). In absence of GOx and CAT, the cathodic oxygen reduction signal
appears at potentials lower than 600 mV vs Ag/AgCl at the PGE.
Figure 3.25 shows that after addition of glucose, GOx and CAT to the electrochemical
cell oxygen is efficiently removed from the electrolyte. The remaining background cur-
rent is comparable or even lower than the one obtained after purging the electrolyte with
inert gas for 20 min (usual method for oxygen removal).
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Figure 3.25: Cyclic voltammograms of PGE/ccNiR/PEG at 20 mV s -1 in 10 mL of 0.1 M
KCl and tris-HCl 50 mM pH 7.6; (a) GOx (12.5 µM, 15 UmL -1 ) and CAT (16.6 µM, 2 kU
mL -1 ) in solution (b) GOx (12.5 µM, 15 UmL-1), CAT (16.6 µM, 2 kU mL-1) and glucose
(50 mM) in solution.
Next, the addition of nitrite to the cell reveals an increase in the catalytic current of
ccNiR, indicating that the nitrite biosensor remains functional and is able to detect nitrite
in the presence of the oxygen scavenging system. (Figure 3.26).
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Figure 3.26: Cyclic voltammogram with PGE at 20 mV s -1 in 10 mL of 0.1 M KCl and tris-
HCl 50 mM pH 7.6; (a) upon addition of GOx (12.5 µM, 15 UmL -1 ) and CAT (16.6 µM, 2
kU mL -1 ) and with the addition of glucose (50 mM).(b) addition of 100 mM Nitrite.
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After confirming the GOx-Catalase-glucose ability to remove oxygen from solution,
the efforts were focused on immobilizing the oxygen removal system on the ccNiR bio-
electrode in order to constitute a fully integrated biosensor. As a first attempt, catalase
was immobilized on the sol-gel matrix and GOx and glucose were added to the unpurged
electrolyte. As can be observed in Figure 3.27, this system is not effective for oxygen
removal, since the cathodic oxygen currents are still present. Most likely, catalase is not
active in the sol-gel film or the amount of immobilized enzyme is not enough to complete
the cycle of oxygen removal in the vicinity of the electrode surface. Next, the electrolyte
solution was thoroughly purged with argon to remove oxygen from solution, however
as confirmed by the green curve in Figure 3.27A the cathodic currents are not eliminated.
At this point it is very likely that the GOx (and glucose in solution) has produced high
amounts of hydrogen peroxide which, due to the lack of catalase in solution, is accu-
mulating and originating the cathodic currents observed after purging the solution. In
order to remove the accumulated peroxide, catalase was then added to the solution and,
in effect, the cathodic currents were eliminated. Interestingly, upon nitrite addition to the
cell, no nitrite reduction currents were observed, which could indicate that the hydrogen
peroxide may have inactivated ccNiR.
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Figure 3.27: Cyclic voltammogram with ccNiR/CAT immobilized in PGE at 20 mV s−1
in 10 mL of 0.1 M KCl and tris-HCl 50 mM pH 7.6; A) ( black ) addition of GOx (12.5 µM,
15 UmL−1 ) and of glucose (50 mM).(green) after purging the electrolyte solution with
argon for 10 min (magenta) CAT (16.6 µM, 2 kU mL−1 ) (blue) 100 mM Nitrite.B) control
experiments performed in the absence of ccNiR. (Red line) increasing hydrogen peroxide
concentrations (0-3mM); (black line) non purged electrolyte.
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The precise chemical mechanisms of the heme destruction are probably very com-
plex. The most plausible hypothesis is that hydrogen peroxide produced by GOx is the
initiating agent in the degradative mechanism203,204. Studies on hydrogen peroxide-
mediated heme degradation have implicated the hydrogen peroxide complex of ferryl
(Fe4+) heme, the ferryl heme itself being produced from a peroxide complex of ferri-
and ferrohemes. The peroxide complex of the ferryl heme readily autoxidizes to form
the highly reactive superoxide radical205,206. The proposed mechanism via initially coor-
dinated peroxide is consistent with the observations of a lack of reactivity of the heme
group of ccNiR. Although there is still a lot of work to be accomplished regarding the
system’s immobilization, the results obtained are very promising from the oxygen scav-
enging system point-of-view. It must be taken into account that the phenomenon of heme
degradation by hydrogen peroxide has yet to be reported with ccNiR.
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Conclusion
4.1 Cytochrome P450 electrochemistry
The electrochemistry of P450 proteins is rather challenging. Several experimental ap-
proaches were tested in order to study this system, ranging from mediated electrochem-
istry with solution and electropolymerized electron shuttles, to direct electron transfer
based systems using surfactants and/or sol-gel films. However, only a few of these
methodologies were successful in channeling the electrons from the electrode to the CYP,
namely, entrapment with long-chained surfactants, DDM and CTAB, and sodium sili-
cate/PEG400 sol-gels.
In this work, P450 DET in a water-based sol-gel thin film is described for the first time.
The electrochemistry of the heme center and the electrocatalytic reaction with O2 was
greatly improved in the presence of PEG400. From the wide range of film compositions
tested, it was shown that only the combination of the sodium silicate inorganic matrix
and the PEG additive enabled the direct electron transfer reaction and the electrocatalytic
activity towards oxygen.
From this thesis, it becomes apparent that the amount of oxygen in the supporting
electrolyte is critical to the PFeIII/PFeII conversion being monitored on the electrode. In
anaerobic conditions, a small non-reversible cathodic peak is observed, whose intensity
increases with the oxygen concentration. On the other hand, in aerobic conditions, a ca-
thodic peak with a high current value is initially observed, which completely disappears
over time. This suggests that the PFeII species is not being regenerated and subsequently
electrochemically reduced.
The results obtained with CYP and CYPOR immobilized in sol-gel, in the presence
of varying oxygen and caffeine concentrations raised several questions for which there is
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not a definite answer - why is there no increase in the catalytic current in the presence of
caffeine? What is the hydrogen’s peroxide relevance for the CYP’s activity? - nonetheless
one thing is clear, the CYP’s catalytic cycle is interrupted in the absence of CPR. One of the
first hypothesis revolved on the prerogative that hydrogen peroxide might have a detri-
mental effect on the catalysis of oxygen by CYP, by promoting heme degradation. How-
ever, there was no improvement in the system’s response in the presence of a peroxidase
(catalase), from which it is possible to infer that if the hydrogen peroxide concentration
was one of the issues, it certainly was not the only one. The next hypothesis - CYP needs
an efficient electron donor, in order to proceed with the substrates conversion, as well
as a specific conformation that may be induced by the interaction with CPR – was sus-
tained by the results. In fact, in the presence of CPR a catalytic response to caffeine was
observed. Most likely, the docking between the two partners (CYP and CPR) is necessary
for CYP to adopt the right conformation. One the other hand, one should not discard
the hypothesis that the stabilizing matrix is not fully biocompatible, hindering the CYP’s
catalytic activity. A decrease in the oxygen catalytic current was observed upon caffeine
addition, indicating that its concentration is being translated into a variation in the oxy-
gen response by, somehow, disturbing the CYP cycle. In contrast, Rusling reported an
increase in the catalytic current while using the same P450 isoform and another substrate
(styrene)187, regardless in his work it is not mentioned if the substrate stock solution was
purged prior to the addition.
4.2 Cytochrome c nitrite reductase electrochemistry
Aiming at the development/optimization of a fully integrated amperometric nitrite biosen-
sor, the hybrid sol-gel used in the studies performed with CYP1A2 was optimized for cc-
NiR. The results observed with different sol-gel formulations are in accordance with the
ones previously obtained with ccNiR, which indicate that large pore matrices are prefer-
able for the enzyme’s immobilization/activity124. Indeed, the PEG6000 polymer (ex-
pected to produce large pore films) is more favorable than PEG400 to maintain the elec-
trocatalysis of nitrite over time. Also, a more favorable orientation might be attained in
this sol-gel, as corroborated by the fact that the cathodic peak’s potential is similar to the
one reported for the catalytic site of ccNir as immobilized on a PG electrode207. Macro-
porous carbon nanotube assemblies have been successfully prepared by electrophoretic
deposition in the presence of a polystyrene template. The quantity of carbon nanotubes
and polystyrene beads in the deposition medium is critical for the proper self-assembly
of the composite film in the 60 V potential field. Cytochrome c nitrite reductase was
deposited on the surface of these macroporous CNT electrodes and then used for the
electrocatalytic detection of nitrite. A direct correlation was observed between the de-
position time and the ccNiR’s electrochemical response to the substrate, as shown by
an increase in the catalytic current with nitrite concentration. Most likely, the greater
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nanotube surface area generated with longer deposition times allows the electrical con-
nection of a higher amount of electroactive enzyme. There are still other venues that
have to be followed in order to ascertain the real weight of this approach, namely the
interference with the size of the PS beads in the ccNiR’s response to substrate. An oxy-
gen removal system based in an oxidase, in the presence of its aldohexose substrate, and
catalase was investigated for field biosensor applications. Electrochemical measurements
under ambient air were free of oxygen interferences, even for electrolyte volumes of 10
mL. Quantification of nitrite, in an open cell with an electrochemical biosensor based on
ccNiR as the biorecognition element and GOx as O2 reduction catalyst was demonstrated.
Interestingly, the results obtained during the study of this oxygen scavenger system - the
bioelectrode lost its activity after being exposed to a high concentration of peroxide -
uphold previous theories postulating that hydrogen peroxide might contribute to heme
group degradation208. Although, thus far it was not possible to immobilize the oxygen
scavenger system, this approach was successful in maintaining anaerobic conditions in
the model nitrite biosensor described, proving itself a promising, simple and inexpensive
oxygen removal methodology.
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Future work
5.1 Cytochrome P450 electrochemistry
Several authors have proposed that any electrochemical experiments of immobilized
P450 should be accompanied by control experiments with P420 (the inactive form), as
well as an iron-protoprofirin group or other heme proteins such as myoglobin. Therefore
as future work we propose to repeat this experiments using two working electrodes, one
with immobilized P450 and the other with immobilized P420. Voltammograms should
then be measured under identical conditions by switching between the two working elec-
trodes. This would allow us to assure that the P450 has not been inactivated and detect
other possible electrochemical artefacts. Another interesting experiment would be to co-
immobilized catalase with P450 and P420 with the aim of reducing or eliminating hydro-
gen peroxide.
Additionally, other immobilization matrices should be tested with the CYP/CYPOR
system in order to improve the electrochemical response and catalysis. Furthermore,
other P450 substrates should be tested, for example propanolol and paracetamol.
Seeing that, the electron tunneling with DET is not mimicking the physiological elec-
tron pathway, future parallel studies could be performed with different redox mediators
and electrochemical potential windows in order to access CYP’s activity.
5.2 Cytochrome c nitrite reductase electrochemistry
The hybrid sol-gel developed in this thesis is a very promising biocompatible matrix,
mainly due to the fact that is a water based formulation. Therefore, future work should
strive to improve this matrix, for instance for application in nitrite biosensors. These
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attempts should comprise further optimization of the sodium silicate, PEG and ccNiR
ratios in the sol-gel film, the use of different molecular weight PEGs or the incorporation
of other sol-gel stabilizing agents, such as PEI. It would also be quite interesting to per-
form surface characterization, of these bioelectrodes, in order to confirm effective enzyme
immobilization, by scanning electron microscopy or atomic force microscopy.
Regarding the macroporous nanotubes electrode modification system, future endeav-
ors should cover a more detailed study of the importance of the CNT’s film porosity. That
being said, the GC-plates should be functionalized with varying deposition times with
and without PS-beads.
In the future, whichever sensor platforms used, it will be beneficial to promote the
enzyme molecules structural orientation on the bioelectrodes, which would guarantee a
greater reproducibility in the amount of electrically-wired enzyme and, consequently, the
biosensor’s response. This could be achieved by the use of functionalized materials, such
as self-assembled monolayers or gold nanoparticles.
In order to implement the enzymatic oxygen scavenger system in biosensors, its im-
mobilization must be accomplished; the sol-gel matrix here described should be opti-
mized for this purpose or a different encapsulation material could be tested.
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